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Discrete survival data are routinely encountered in many fields of study. There are
two common types of discrete survival data. The first type is derived discrete, which
is originally continuous but recorded in a discrete version by grouping or rounding into
a discrete time. The second type is intrinsically discrete. The dissertation research is
motivated by two types of discrete survival data in clinical trials.
We develop a class of proportional exponentiated link transformed hazards (ELTH)
models and a class of proportional exponentiated link transformed survival (ELTS) models.
We examine the role of links in fitting discrete survival data and estimating regression
coefficients. We also characterize the conditions for improper survival functions and the
conditions for existence of the maximum likelihood estimates under the proposed ELTH
models. An extensive simulation study is conducted to examine the empirical performance
of the parameter estimates under the Cox proportional hazards model by treating discrete
survival times as continuous survival times, and the model comparison criteria, AIC and
BIC, in determining links and baseline hazards. A SEER breast cancer dataset is analyzed
in details to further demonstrate the proposed methodology.
Previous research has shown that outcome misclassification can bias estimation of the
survival function under standard survival methods. We develop methods to accurately
estimate the survival function when the diagnostic tool used to measure the outcome of
disease is not perfectly sensitive and specific. Since the diagnostic tool used to measure
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disease outcome is not the gold standard, the true outcomes cannot be observed. Our
method uses the negative predictive value (NPV) and the positive predictive values (PPV)
to construct a bridge between the mismeasured outcomes and the true outcomes. We
formulate an exact relationship between the true and the observed survival functions as a
formulation of time-varying NPV and PPV. We specify models for the NPV and PPV that
depend only on parameters that can be easily estimated from a fraction of the observed
data. Furthermore, we extend and conduct an extensive study to accurately estimate the
latent survival function based on the assumption that the underlying disease process follow
a stochastic process. We further examine the performance of our method by applying it
to the VIRAHEP-C data.
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Chapter 1
Introduction
1.1 Types of Discrete Time Survival Data
Discrete time survival data are common in social science, behavior science, economics,
and biomedical science. Discrete time survival data analysis can be found in many ap-
plications in the literature, such as a study of family reunification using the foster care
data in Wulczyn et al. (2011), the etiology of early-onset smoking behavior using the
longitudinal data in Fairchild et al. (2013), the bankruptcy prediction using the financial
data in Nam et al. (2008), the host selection of spring tiphia and summer tiphia using
the discrete survival data of oriental beetles grubs in Obeysekara (2013), and an analysis
of the discrete survival data from the study of Viral Resistance to Antiviral Therapy of
Chronic Hepatitis C (Virahep-C) in Adeniji et al. (2014).
In the Surveillance, Epidemiology, and End Results (SEER) database, only the month
and year but not the day of death or last follow-up or diagnosis are available due to patient
confidentiality consideration. Thus, it is quite natural to consider these event times as
discrete survival times. In the aforementioned applications, there are two common types
of discrete survival data. The first type is that the survival time is originally continuous
1
2but recorded in a discrete version by grouping or rounding into a discrete time. We call
this type as “derived discrete”. The survival time in the SEER database is an example
of this type since the survival time in the unit of months is a rounded number due to
patient confidentiality consideration. For this type of data, interval censoring data analysis
approaches can be applicable. However, it is common that we do not have any information
which method is used to be rounded. It is reasonable to analyze the data using discrete
survival data analysis methods.
The second type is “intrinsically discrete”. An example of the intrinsically discrete
time survival data is the viral levels of Hepatitis C virus (HCV) data. In the clinical
practice, the viral levels of HCV are measured only at patient’s visit time points and
an event of interest occurs only when the viral level is below a detection limit at the
first time over these visits, which is called low detection limit problem. In this case, the
information about the underlying viral process is observed only at the visit time points,
but no information about viral levels is available between any two consecutive visit time
points.
For example, Figure 1.1 shows the implemented viral loads under Brownian motion
(BM) process with low detection limit as 50 IU/ml. Even though the viral negativity can
happen anytime and the true event may have already occurred between t1 and t2, we do
not have any information about the viral levels between patient’s visits and observe the
viral level lower than 50 IU/ml only at the sixth patient’s visit. Thus, the survival time
is intrinsical and it is recorded as t6 in this example.
3Time
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Figure 1.1: Implemented viral loads under Brownian motion process for an example of
intrinsically discrete data.
1.2 Literature Review on Modeling of Survival Data
Allison (2004) discussed a logistic regression model for discrete time hazards. Kalbfleisch
and Prentice (1973) developed a discrete hazard model for grouped data. Other statistical
methods for modeling discrete time survival data have been developed in the literature,
including Prentice and Gloeckler (1978); Stewart and Pierce (1982); Efron (1988); Singer
and Willet (1993); Biggeri et al. (2001); Grilli (2005); Muthen and Masyn (2005); Manda
and Meyer (2005); Brown et al. (2009); and Nguyen and Gillen (2012).
Alternative approaches for the derived discrete survival data are methods for interval
censored survival data. There have been abundant literatures on the interval censored
survival data analysis including Sun (2006); Tian and Cai (2006); Chen et al. (2007);
Peng and Huang (2007); Koma´rek and Lesaffre (2008); Zhao et al. (2008); Liu and Shen
(2009); Li and Ma (2010); Kim (2010); Ma (2010); Xiang et al. (2011); Wang et al. (2013);
and Wu and Cook (2015).
4Berkson and Gage (1952) proposed the mixture cure rate model for survival data with
long term survivors or cured individuals. The mixture cure rate model has been extensively
investigated in the literature, including Farewell (1982); Kuk and Chen (1992); Sy and
Taylor (2000); Peng and Dear (2000); Fang et al. (2005); Lam and Xue (2005); Li et al
(2007); Yu (2008); Zhang and Peng (2009); Othus et al. (2009); Ma (2010); and Wang et
al. (2012).
An alternative modeling strategy for survival data with a cured fraction has been
proposed and discussed in Tsodikov (1998); Chen et al. (1999); Ibrahim et al. (2001);
Tsodikov et al. (2003); Zeng et al. (2006); and Gu et al. (2011). However, most of the
aforementioned articles focus on continuous time survival data.
Steele (2003) developed the discrete time multi-level mixture model with long term
survivors, which allows random effects for unobserved individual heterogeneity in the haz-
ard of event occurrence. Zhao and Zhou (2008) proposed a discrete time proportional
hazards model with long term survivors as an extension of the mixed discrete and con-
tinuous Cox’s regression model in Prentice and Kalbfleisch (2003) by allowing improper
baseline survival function.
Transformation models on the failure time has been studied by Cheng et al. (1997),
and Chen et al. (2002). Chen et al. (2002) developed the linear transformation models
on the failure time. Alternatively, the transformation models on survival function has
been discussed by Cheng et al. (1995); Fine et al (1998); Cai et al. (2000); Cai and Cheng
(2004); and Banerjee et al. (2007). Cheng et al. (1995) developed a class of semi-parmetric
linear transformation model on survival function.
51.3 Discrete Survival Data with Mismeasured Outcomes
The time-to-first-event is important in clinical studies, these endpoints are generally
analyzed using survival analysis techniques. However, standard survival techniques as-
sume there is no error in disease classification. In the presence of misclassified outcomes,
standard survival techniques like the Kaplan-Meier estimator is biased in estimating the
true survival rate. Incorrect survival and hazard rates can lead to false clinical trial conclu-
sions. As a result of this problem, we build an estimator of the true (latent) survival rate
which incorporates the negative predictive value (NPV) and the positive predictive values
(PPV) of the diagnostic test into its construction. The NPV and PPV of the diagnostic
tool provides a link between the misclassified (events measured with error) population and
the true (latent) population.
Racine-Poon and Hoel (1984) derived a nonparametric estimation of the survival func-
tion for which the cause of death was uncertain. Snapinn (1998) proposed modifying the
Cox proportional hazards regression model to incorporate information from all potential
endpoints as well as the level of uncertainty. Their proposed variance estimates are correct
only for certain joint distributions of the event histories. Richardson and Hughes (2000)
used the Expectation Maximization (EM) algorithm to obtain unbiased estimates of the
conditional probability of disease when the diagnostic test has less than perfect sensitivity
or specificity. Magder and Hughes (1997) incorporated sensitivity and specificity into the
estimation of the parameters in a logistic regression model, their regression coefficients
and their standard errors were estimated using the EM algorithm. McKeown and Jewell
(2010) extended the nonparametric maximum likelihood estimator (NPMLE) to allow for
time-dependent misclassification rates.
6For mismeasured data, we build an estimator of the true survival rates with the use of
NPV and PPV and assume these quantities change over time. The new method provides
a link between the misclassified (events measured with error) population and the true
(latent) population. We believe our method compliments existing research by providing a
method that uses NPV and PPV rather than sensitivity and specificity.
1.4 Overview of Dissertation
The rest of the thesis is organized as follows. In Chapter 2, we provide a detailed de-
velopment of the proposed proportional exponentiated link transformed hazards (ELTH)
models and proportional exponentiated link transformed survival (ELTS) models, examine
various properties of the proposed models including the choice of links and the conditions
for improper survival functions under ELTH models and ELTS models, and present the
likelihood function and the conditions for existence of the maximum likelihood estimates.
An extensive simulation study and a detailed analysis of the SEER breast cancer data are
given in Chapter 3. We provide a detailed development of exact relationship between sur-
vival function and observed survival function, and the proposed models, examine various
properties of the proposed models, and provide inference procedure and implementation
procedures. Also An extensive study under stochastic process and a detailed analysis of
the VIRAHEP-C data are carried out in Chapter 4. We conclude the thesis with some
discussion, discuss future research and extend proposed method in Chapter 4 to upper
detection limit problem under Gamma process in Chapter 5. The proofs of theorems are
given in Appendix A.
Chapter 2
Data and Methods
2.1 Introduction
In the thesis, we develop a new class of proportional exponentiated link transformed
hazards (ELTH) models for discrete time survival data. The ELTH model is attractive
since it mimics the Cox proportional hazards model for continuous failure times and the
class of ELTH models are flexible and rich, which include existing discrete hazard models
such as the logistic regression model Allison (1982), the continuous-time proportional
hazards generated model of Kalbfleisch and Prentice (1973), and the cure rate model of
Zhao and Zhou (2008) as special cases. We discuss the conditions for improper survival
functions under the proposed ELTH models. The conditions for existence of the maximum
likelihood estimates are characterized and an illustrative example is given.
The proposed approach is quite different than those developed in Cheng et al. (1995),
Chen et al. (2002), and Banerjee et al. (2007). Specifically, in the class of ELTH models,
we make the transformation directly on the hazard function. We note here that the
transformation approach on the failure time considered in Chen et al. (2002) is not directly
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8applicable to discrete survival data since the distribution of a discrete failure time is
unchanged after a one-to-one monotone transformation.
Instead of ELTH models, we take the transformation directly on the survival function
following Cheng et al. (1995) and Banerjee et al. (2007). For the modeling of survival
function, we develop proportional exponentiated link transformed survival (ELTS) mod-
els for discrete time survival data. A nice feature of this new formulation is that it directly
connects the models discussed in Cheng et al. (1995) and Banerjee et al. (2007) for contin-
uous survival data. Unlike the ELTH model, link transformed baseline needs to be strictly
decreasing in survival time and likelihood function under ELTS model is similar to that
for the ordinal data while the likelihood function under ELTH model is similar to that for
the binary data.
2.2 The SEER Breast Cancer Data
To motivate the proposed methodology, we consider a subset of the Surveillance, Epi-
demiology, and End Results (SEER) data from the National Cancer Institute (NCI) with
2096 female subjects who were at least 20 years old at diagnosis and were diagnosed with
regional extension, grade III or IV, and stage III breast cancer between 1990 and 2003.
For the subset of the SEER breast cancer data, among the 2096 female subjects, 1222
(58.3%) died after a median follow-up of 68 months (interquartile range (IQR): (27, 97.5)
months) from the time of diagnosis. Based on Althuis et al. (2004) and Ries and Eisner
(2007), the covariates considered in our analysis include age, tumor size (Size), extension of
the primary tumor (Ext), positive lymph node involvement (PN), estrogen receptor status
(ER), progesterone receptor status (PR), race, grade indicator, and treatment indicators.
For the continuous covariates, the medians and IQRs of age, Size, and Ext were 55 and
9(45, 68) years, 60 and (40, 75) millimeters, and 15 and (11, 20) millimeters, respectively.
The variables PN, ER, PR, race, and grade are binary covariates, taking value 0 or 1.
Specifically, PN = 1 if the number of highest involved positive lymph nodes ≤ 5; ER = 1
if estrogen status is positive; PR = 1 if progesterone status is positive; race = 1 if not
black; and grade = 1 if grade III. The treatment indicators include two binary variables,
radiation (Rad) and Surgery (Surg), where Rad = 1 if radiation therapy received and Surg
= 1 if surgery performed. The numbers of patients with the value 1 were 1071, 1118, 912,
1723, 1987, 1296, and 2025, respectively, for PN, ER, PR, race, grade, Rad, and Surg.
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Figure 2.1: The plot of the estimated hazard versus time for the SEER breast cancer data.
For this study cohort, we calculate a na¨ıve estimate of the hazard at time tk as
hˆ(k) =
number of events at time tk
number of subjects at risk at time tk
.
A plot of hˆ(k) versus tk is shown in Figure 2.1. From this figure, we observe that all of
the estimated hazards are less than 0.02.
Figure 2.2 shows the Kalplan and Meier estimates of survival function. The range
of survival rates are 0.34 to 1. Also, Figure 2.3 shows that the estimated survival rates
of groups with three different treatments, both surgery and radiation, surgery only, and
10
Month
Sur
viva
l Ra
te
0 20 40 60 80 100 120
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
Figure 2.2: The plot of the estimated survival rates versus time for the SEER breast
cancer data.
other. The minimums of the estimated survival rates are correspondingly 0.409, 0.257,
and 0.142 for the treatment groups, both surgery and radiation, surgery only, and other.
Compared to the plot of hazard in Figure 2.1, The survival curve covers a wider range.
This indicates the potential possibility in the role of the links in fitting hazards and survival
rates. Thus, the choice of links for survival rates is different than that for hazards.
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Figure 2.3: The plot of the estimated survival rates of different treatment groups versus
time for the SEER breast cancer data.
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2.3 The Methods
2.3.1 Preliminary
Let T be a discrete random variable taking only positive values 0 < t1 < t2 < · · · .
Then the discrete time hazard function at tk is defined as
h(k) = P (T = tk|T ≥ tk). (2.1)
After some algebra, the probability of T = tk can be expressed as
P (T = tk) = h(k)
k−1∏
j=1
{1− h(j)}, k = 1, 2, . . . , (2.2)
where
∏0
j=1{1− h(j)} = 1. The corresponding survival function at time tk is given by
S(k) = P (T > tk) =
k∏
i=1
{1− h(i)} = exp
[ k∑
i=1
log{1− h(i)}
]
, (2.3)
for k = 1, 2, . . . . For an arbitrary time t, the discrete time survival function can be written
as follows ∏
i:ti≤t
{1− h(i)} ≡ S(kt),
where kt = max{i : ti ≤ t}. Let x denote a vector of baseline covariates and also let β be
a vector of the corresponding regression coefficients. To develop a regression model, Cox
(1972) proposed the following discrete time hazard regression model:
h(k|x,β)
1− h(k|x,β) =
h0(k)
1− h0(k) exp(x
′β), (2.4)
where h0(k) is the baseline discrete hazard function at time tk. Taking the logarithm of
both sides of (2.4) gives
logit(h(k|x,β)) ≡ log
{ h(k|x,β)
1− h(k|x,β)
}
= log
{ h0(k)
1− h0(k)
}
+ x′β. (2.5)
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Letting αk = log
{
h0(k)
1−h0(k)
}
, we have
h(k|x,β) = exp(αk + x
′β)
1 + exp(αk + x′β)
for k = 1, 2, . . . . The logistic regression model in (2.5) is one of the most popular models
for discrete survival time data (e.g., see Allison (1982)).
Kalbfleisch and Prentice (1973) developed the discrete model for the grouped data
from the Cox’s model with the hazard function given by
h(k|x,β) = 1− [1− h0(k)]exp(x′β), (2.6)
where the survival time in the interval [ak−1, ak) is recorded as tk, a0 = 0 < a1 < . . . ,
and h0(k) is the baseline discrete hazard function. From (2.6), we have
log[− log{1− h(k|x,β)}] = log[− log{1− h0(k)}] + x′β (2.7)
and
h(k|x,β) = 1− exp[− exp(αk + x′β)], (2.8)
where αk = log[− log{1 − h0(k)}] for k = 1, 2, . . . . As discussed in Allison (1982), the
discrete time hazard function is (2.8) if the data are generated by the continuous time
proportional hazards model. Another discrete hazard regression model proposed by Zhao
and Zhou (2008) assumes
h(k|x,β) = 1−
[1− pi + pi∏kj=1(1− hZ0 (j))
1− pi + pi∏k−1j=1(1− hZ0 (j))
]exp(x′β)
, (2.9)
where 0 < hZ0 (k) < 1 for k = 1, 2, . . . , 0 < pi ≤ 1, and
∏0
j=1{1−hZ0 (j)} = 1. We note that
(2.9) is more general than (2.6) since (2.9) reduces to (2.6) when pi = 1 and hZ0 (k) = h0(k).
Let SZ0 (k) =
∏k
j=1(1−hZ0 (j)), which defines a discrete time survival function. Then, Zhao
and Zhou (2008) assumed that SZ0 (k) is a proper survival function, that is,
SZ0 (∞) = lim
k→∞
SZ0 (k) = 0, (2.10)
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which implies
∞∏
j=1
(1− hZ0 (j)) = 0. (2.11)
In general, any hazard function that satisfies (2.11) defines a proper survival function.
Let S(k|x,β) denote the survival function corresponding to (2.9). Then, using (2.1) and
(2.13), we have
h(k|x,β) = 1− S(k|x,β)
S(k − 1|x,β) , (2.12)
where S(0|x,β) = 1. The discrete time survival function at time tk can be rewritten as
S(k|x,β) = P (T > tk|x,β) =
∞∑
i=k+1
P (T = tk|x,β), (2.13)
where P (T = tk|x) is the probability at time tk. Let T (c) be a continuous random variable
with T (c) ≥ 0.
Cheng et al. (1995) proposed the linear transformed survival model for continuous
survival time at T (c) = t, as follows
η{S(t|x,β)} = g(t) + x′β, (2.14)
where η(·) is a known decreasing function and g(t) is a unspecified strictly increasing
function. The model in 2.14 includes the Cox model and proportional odd model by taking
η(·) as log[− log(·)] for Cox model and −logit(·) for proportional odd model. Combining
(2.9) and (2.12) leads to
S(k|x,β) =
[
1− pi + pi
k∏
j=1
{1− hZ0 (j)}
]exp(x′β)
= [1− pi + piSZ0 (k)]exp(x
′β), (2.15)
where SZ0 (·) is a proper survival function, which is SZ0 (∞) = 0 in (2.10). From (2.3.8), it
is easy to see that
S(∞|x,β) = (1− pi)exp(x′β)
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since SZ0 (∞) = 0. Thus, if pi < 1, S(k|x,β) is not a proper survival function. Now, it is
also clear that 1− pi represents the cured fraction of the baseline population.
2.3.2 The Proposed Hazard Models
From (2.1), we see that the discrete time hazard rate function h(k) is the conditional
probability of an event of interest occurring at time tk, given that the event has not
occurred yet prior to tk and, hence, 0 < h(k) < 1. When there are subject-dependent
covariates (x), one of the key issues is how to model h(k), i.e., how to link h(k) to x, for
discrete survival data. By extending (2.5) and (2.7), we propose the following additive
model for the hazard function:
F−1(h(k|x,β)) = αk + x′β, (2.16)
where F is a continuous cumulative distribution function (cdf) and F−1 is the inverse
function of F . Throughout the thesis, we assume 0 < F (u) < 1 for −∞ < u < ∞. In
(2.16), F−1 is called a link function. When F−1(u) = logit(u) = log( u1−u) (logit), (2.16)
reduces to (2.5) with αk = logit(h0(k)) and similarly, when F
−1(u) = log{− log(1 − u)}
(C-log-log), (2.16) reduces to (2.7) with αk = log[− log{1 − h0(k)}], where h0(k) is the
baseline hazard function. Setting αk = F
−1(h0(k)), we can rewrite (2.16) as follows:
exp{F−1(h(k|x,β))} = exp{F−1(h0(k))} exp(x′β). (2.17)
The model in the form of (2.17) is attractive since it mimics the Cox proportional hazards
model for continuous failure times. Thus, the proposed model can be viewed as the
proportional exponentiated link transformed hazards (ELTH) model and αk is called the
link transformed baseline hazard function. If we take F−1(u) = log{− log(1− u)} and let
h0(k) =
pihZ0 (k)
∏k−1
j=1{1− hZ0 (j)}
1− pi + pi∏k−1j=1{1− hZ0 (j)} , (2.18)
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where hZ0 (k) is defined in (2.9), the model in (2.16) or (2.17) reduces to (2.9). Therefore,
the cure rate model of Zhao and Zhou (2008) is a special case of the ELTH model.
2.3.3 The Choices of Links
From (2.2) and (2.13), we see that events {T = tk} and {T > tk} are equivalent to
events {Y1 = 0, . . . , Yk−1 = 0, Yk = 1} and {Y1 = 0, . . . , Yk−1 = 0, Yk = 0}, respectively,
where Y1, . . . , Yk are k binary random variables taking values of 0 or 1 such that the Y`’s
are independent and Y` ∼ Bernoulli(h(`)) for ` = 1, . . . , k. Thus, discrete survival time
data can be viewed as binary response data. For binary response data, as discussed in
Stukel (1988), Czado and Santner (1992), Chen et al. (1999), and Kim et al. (2008), the
misspecification of the link may yield substantial bias in the mean response estimates and
a skewed link may fit the data much better than a symmetric link or vice versa. However,
for discrete survival data, the hazards, h(k)’s, are typically small. As shown in Figure 2.1,
all of the na¨ıve estimates of the hazards are less than 0.02 for the SEER breast cancer
data. When the hazards are less than 0.5, the half of the link corresponding to the portion
of the cumulative distribution function (cdf) F with F ≥ 0.5 does not play any role in
fitting discrete survival data. We now state a useful proposition.
Empirical Observation
Let F1 and F2 be two cdf’s. Let (α
(1)
k ,β
(1)) and (α
(2)
k ,β
(2)) be the respective parameters
corresponding to F1 and F2 in (2.16). If there exist constants c1 > 0 and c2 such that (i)
lim
u→−∞[F1(c1u+ c2)/F2(u)] = 1 or (ii) limu→−∞[F1(u)/ F2(c1u+ c2)] = 1, then we have
α
(1)
k ≈ c1α(2)k + c2 and β(1) ≈ c1β(2) for (i) and α(2)k ≈ c1α(1)k + c2 and β(2) ≈ c1β(1) for
(ii), where “≈” denotes “approximately equals”, when the hazards are small.
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We note that when the hazards are sufficiently small, F1(c1u+c2)/F2(u) (or F1(u)/F2(c1u+
c2)) will be close to 1. For example, when F
−1
1 (u) = log{− log(1 − u)} and F−12 (u) =
log( u1−u), we obtain that F1(u) ≤ 0.08, F2(u) ≤ 0.08, and |F1(u)/F2(u) − 1| ≤ 0.04 for
u ≤ −2.5; F1(u) ≤ 0.05, F2(u) ≤ 0.05, and |F1(u)/F2(u) − 1| ≤ 0.025 for u ≤ −3; and
F1(u) ≤ 0.02, F2(u) ≤ 0.02, and |F1(u)/F2(u)−1| ≤ 0.01 for u ≤ −4. Based on our empir-
ical experience, the estimates under the ELTH model with the logit link are practically the
same as those under the ELTH model under the C-log-log link when the hazards are less
than 0.08. Thus, the hazards would be considered to be small when they are about 0.08
or less. The practical implication of our Empirical Observation is that the ELTH model
with a symmetric link may fit discrete survival data as equally well as the ELTH model
with an asymmetric link when the hazards are small. These properties will be examined
in details in the simulation study in Section 3.1 and a real data analysis in Section 3.2.
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Figure 2.4: The plots of the cumulative distribution functions corresponding to the probit,
logit, C-log-log, t4, and standard Laplace links, where the whole cdf curve is shown in (a)
and the enlarged portion of cdf over (−6,−3) is shown in (b).
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Figure 2.4 shows the cdf plots for the probit, logit, C-log-log, t4, and standard Laplace
links, where F is the standard normal cdf Φ under the probit link, F is the standard t-
distribution function with 4 degrees of freedom under the t4 link, and the standard Laplace
cdf is given by F (u) = 12 exp(u) if u < 0 and 1 − 12 exp(−u) if u ≥ 0. Among these five
links, the C-log-log link is skewed while other four are symmetric. If we compare the entire
curves shown in Plot (a) of Figure 2.4, all five cdf’s are different. If we compare the curves
shown in Plot (b) of Figure 2.4, we observe that (i) the C-log-log and logit links are almost
indistinguishable; (ii) the t4 (probit) cdf approaches to 0 at a much slower (faster) rate
than the cdf’s under other four links; and (iii) the standard Laplace cdf approaches to 0
at a faster rate than both the C-log-log and logit cdf’s but a slower rate than the probit
cdf. Let F1(u) = exp(u)/{1 + exp(u)}, F2(u) = 1− exp{− exp(u)}, and F3(u) = 12 exp(u)
for u < 0 be the cdf’s corresponding to the C-log-log, logit, and standard Laplace links.
Then, we can show that lim
u→−∞[F1(u)/F2(u)] = 1 and limu→−∞[F1(u)/F3(u + log 2)] = 1.
Although the C-log-log link is different than the logit link as shown in Plot (a) of Figure
2.4 as well as the standard Laplace link as shown in Plot (b) of Figure 2.4, these three
links will yield similar estimates of the regression coefficients (β) and a similar fit of the
discrete survival data when the hazards are small according to our Empirical Observation.
Thus, the choice of links in fitting discrete survival data is quite different than the one in
fitting general binary response data.
2.3.4 The Cure Rates under the ELTH Models
Using (2.11) and (2.18), it is easy to see that
lim
k→∞
h0(k) = 0
18
and
lim
k→∞
αk = lim
k→∞
log[− log{1− h0(k)}] = −∞, (2.19)
if pi < 1. Thus, the cure rate model implies (2.19).
Next, we examine the conditions on F and h0(k) under which the ELTH model induces
a cure rate model. We first state two assumptions on αk and F as follows.
Assumption 2.1: limk→∞ αk = −∞ and for a given c, there exist k0 > 0 and d > 0 such
that αk + c < 0 and
F (αk + c) ≤ d exp(αk + c) for all k ≥ k0.
Assumption 2.2: limk→∞ αk = −∞ and for a given −∞ < c < ∞, there exist k0 > 0,
d > 0, and r > 0 such that αk + c < 0 and
F (αk + c) ≤ d
(−αk − c)r for all k ≥ k0.
It is easy to see that if F satisfies Assumption 2.1, F automatically satisfies Assumption
2.2. Thus, the conditions in Assumption 2.1 are stronger than those in Assumption 2.2.
Remark 2.1: Assumption 2.1 holds for the distribution functions corresponding to
the logit, C-log-log, and probit links. For the logit link, we have
F (αk + c) =
exp(αk + c)
1 + exp(αk + c)
≤ exp(αk + c).
For the C-log-log link, we can show that
F (αk + c) = 1− exp{− exp(αk + c)} ≤ exp(αk + c)
based on the fact that g(y) = 1 − exp(−y) − y is a decreasing function of y for y > 0
and g(0) = 0. Thus, Assumption 2.1 holds for d = 1, all αk’s and all k > 0 for the cdfs
19
corresponding to the logit and C-log-log links. Since αk goes to −∞, there exists k0 > 0
such that αk+c < −2 for all k > k0. Thus, if k > k0, we have Φ(αk+c) ≤ 1√2pi exp(αk + c).
Remark 2.2: If F is the cdf of a t-distribution with ν degrees of freedom, then F satisfies
Assumption 2.2 only. It is easy to show that when αk + c < −1 for all k ≥ k0, we have
d1
(−αk − c)ν ≤ F (αk + c) ≤
d2
(−αk − c)ν ,
where d1 =
Γ( ν+1
2
)
ν
√
νpiΓ( ν
2
)
( νν+1)
ν+1
2 and d2 =
Γ( ν+1
2
)√
pi Γ( ν
2
)
ν
ν−2
2 . Thus, the cdf of a t-distribution
satisfies Assumption 2.2 but does not satisfy Assumption 2.1.
Using (2.13) and (2.16), we have
S(k|x,β) = exp
[ k∑
i=1
log{1− F (αi + x′β)}
]
. (2.20)
If S(k|x,β) is not proper, i.e., S(∞|x,β) > 0, then we must have
lim
k→∞
log{1− F (αk + x′β)} = 0. (2.21)
When F ′(u) = dF (u)du > 0, (2.21) implies limk→∞ αk = −∞. Consequently, we have
limk→∞ h0(k) = 0 since h0(k) = F (αk). Thus, the condition, limk→∞ αk = −∞, is
necessary for an improper survival function. Now, we establish the sufficient conditions
for an improper survival function in the following theorem.
Theorem 2.3.1. The survival function S(k|x,β) is improper, i.e., S(∞|x,β) > 0 if (i)
αk and F satisfy Assumption 2.1 and
∞∑
k=1
exp(αk) <∞; (2.22)
or (ii) αk and F satisfy Assumption 2.2 with c = x
′β and
∞∑
k=k0
1
(−αk − c)r <∞. (2.23)
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The proof of Theorem 2.3.1 is given in the Appendix. For certain link functions,
(2.22) becomes the necessary and sufficient condition for an improper survival function.
We formally state this result in the following theorem.
Theorem 2.3.2. The survival function S(k|x,β) is improper if and only if (i) (2.22) holds
when F is the cdf corresponding to the C-log-log link or the logit link and (ii) (2.23) with
r = ν holds when F is the cdf of a t-distribution with ν degrees of freedom.
The proof of Theorem 2.3.2 is given in the Appendix. In the next theorem, we present
a sufficient condition for a proper survival function.
Theorem 2.3.3. The survival function S(k|x,β) is proper, i.e., S(∞|x,β) = 0 if
lim
k→∞
αk > −∞.
The proof of this theorem is straightforward and thus the detail of the proof is omitted
for brevity.
Remark 2.3: Suppose F−1(u) = log{− log(1−u)} and ∑∞k=1 exp(αk) <∞. Using (2.18)
and (2.19), we obtain
exp{− exp(αk)} =
1− pi + pi∏kj=1{1− hZ0 (j)}
1− pi + pi∏k−1j=1{1− hZ0 (j)}
and
lim
k→∞
[
−
k∑
i=1
exp(αi)
]
= lim
k→∞
k∑
i=1
log
[1− pi + pi∏ij=1{1− h0(j)}
1− pi + pi∏i−1j=1{1− h0(j)}
]
= log(1− pi).
Thus, the cure rate in (2.9) of Zhao and Zhou (2008) can be expressed as
1− pi = exp
{
−
∞∑
k=1
exp(αk)
}
.
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After some algebra, it is easy to see that
pihZ0 (k)
k−1∏
i=1
{1− hZ0 (i)} = exp
{
−
k−1∑
i=1
exp(αi)
}
− exp
{
−
k∑
i=1
exp(αi)
}
and
hZ0 (k + 1) =
hZ0 (k){exp(−
∑k
i=1 exp(αi))− exp(−
∑k+1
i=1 exp(αi)}
{1− hZ0 (k)}[exp{−
∑k−1
i=1 exp(αi)} − exp{−
∑k
i=1 exp(αi)}]
for k = 1, 2, · · · , where
hZ0 (1) =
1− exp{− exp(α1)}
1− exp{−∑∞k=1 exp(αk)} ,
0∑
i=1
exp(αi) = 0,
and
∏0
i=1{1− hZ0 (i)} = 1. Thus, if
∑∞
k=1 αk <∞, then pi and hZ0 (k) are functions of αk’s
under the ELTH model with the C-log-log link.
As discussed in Remark 2.3, there is a connection between the cure rate model (2.9)
and the ELTH model. This connection indicates that the cure rate model can be a direct
consequence of the ELTH model by properly modeling the baseline hazard h0(k) or the link
transformed baseline hazard αk, which will be discussed in detail in the next subsection.
2.3.5 Modeling the Baseline Hazard Functions
The simplest model for αk is the linear model (e.g., see Allison (1982)) given by
αk = ψ0 + ψ1tk, (2.24)
where tk is the time at which the survival function S(k|x,β) is defined. The following
theorem characterizes the conditions for proper or improper survival functions under the
linear model (2.24).
Theorem 2.3.4. Let Nj = {k : tk ∈ (j − 1, j]} for j = 1, 2, · · · . Suppose tk → ∞ as
k → ∞ and Nmax = supj≥1 |Nj | < ∞, where |Nj | denotes the cardinal number of Nj .
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Then, we have (i) S(∞|x,β) > 0 for F satisfying Assumption 2.1 or Assumption 2.2 with
r > 1 if ψ1 < 0; and (ii) S(∞|x,β) = 0 for any F if ψ1 ≥ 0.
By extending the idea in Efron (1988) and (2.24), we further consider a piecewise
baseline hazard model for αk. We first construct a finite partition of the interval [t1,∞),
s0 = t1 < s1 < s2 < . . . < sJ−1 < sJ =∞. Thus, we have J intervals [t1, s1), [s1, s2), . . . ,
[sJ−1, sJ). We then assume piecewise constants for αk for the first J − 1 intervals and a
linear function for αk in the last interval, that is,
αk =

ψ0 + ψ1tk if J = 1,
ψ0 +
∑J−2
j=1 ψj I{sj ≤ tk < sj+1}+ ψJ−1(tk − sJ−1)+ if J > 1,
(2.25)
where I{sj ≤ tk < sj+1} is the indicator function, which takes a value of 1 if sj ≤ tk < sj+1
and 0 otherwise, and (tk−sJ−1)+ = tk−sJ−1 if tk > sJ−1 and 0 otherwise. From (2.25), we
see that for J > 1, αk = ψ0 for tk < s1 and ψ0 +ψj for sj ≤ tk < sj+1 for j = 1, . . . , J − 2
(i.e., piecewise constants) and αk = ψ0 + ψJ−1(tk − sJ−1) (linear) for tk ≥ sJ−1. When
J = 1, (2.25) reduces (2.24). The conditions for proper or improper survival functions
under the piecewise baseline hazard model (2.25) are similar to those given in Theorem
2.3.4.
The form for αk in (2.25) is quite general and flexible since it can capture any shapes of
the unknown true baseline hazard h0(k) in (2.17) by increasing J . For a given dataset, the
ELTH model with αk in (2.25) may fit the data poorly when J is too small and the fit of the
ELTH model improves when J is large. However, the number of unknown parameters ψj ’s
becomes large and the model may become too complex and even unidentifiable when J is
unnecessarily large. Thus, there is a trade-off between the goodness-of-fit and the model
complexity in the choice of J . To address these issues, we characterize the conditions for
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the existence of the maximum likelihood estimates of the ψj ’s as well as β in Theorem
2.3.5 and propose the Akaike information criterion (AIC) and the Bayesian Information
Criterion (BIC) to guide the choice of J in Section as well as in the simulation study and
the analysis of the breast cancer data.
2.3.6 The Likelihood Function under ELTH Model
Suppose there are n subjects. For the ith subject, let tki denote the discrete failure
time, which may be right-censored, and also let δi denote the censoring indicator such
that δi = 1 if tki is the failure time and 0 otherwise. We further let xi = (xi1, . . . , xip)
′
denote a p-dimensional vector of covariates. Write D = {(tki , δi,xi), i = 1, . . . , n}, which
is the observed data. Then, the observed data likelihood function under the ELTH model
can be written as
L(β, h0|D) =
n∏
i=1
[Pr(Ti = tki |xi,β, h0)]δi [Pr(Ti > tki |xi,β, h0)]1−δi
=
n∏
i=1
[ h(ki|xi,β)
1− h(ki|xi,β)
]δi
S(ki|xi,β),
=
n∏
i=1
[h(ki|xi,β)]δi [1− h(ki|xi,β)]1−δi
ki−1∏
j=1
1− h(ki|xi,β)
=
n∏
i=1
ki∏
j=1
[h(j|xi,β)]yij [1− h(j|xi,β)]1−yij (2.26)
where β is an p-dimensional vector of regression coefficients corresponding to xi, h0 is the
baseline hazard function, and h(ki|xi,β) and S(ki|xi,β) are defined by (2.16) and (2.20),
respectively. Also, yij a binary response variable with value 1 if the failure time of i− th
subject is tj . The form of the likelihood in (2.26) is analogues to the one for the binary
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response data. After some algebra, (2.26) can be rewritten as
L(β, h0|D) =
n∏
i=1
{ F (αki + x′iβ)
1− F (αki + x′iβ)
}δi ki∏
j=1
{1− F (αj + x′iβ)}
=
n∏
i=1
ki∏
j=1
{F (αj + x′iβ)}yij{1− F (αj + x′iβ)}1−yij .
2.3.7 The Existence of the MLE under the ELTH Model
Now, we characterize the conditions for the existence of the maximum likelihood es-
timate (MLE). For ease of exposition, we consider the piecewise baseline hazard model
(2.25) for the αk. Let zim = (1, tm, x
′
i)
′ for J = 1, zim = (1, (tm − s1)+, x′i)′ for
J = 2, and zim = (1, I{s1 ≤ tm < s2}, . . . , I{sJ−2 ≤ tm < sJ−1}, (tm − sJ−1)+, x′i)′ for
J > 2, m = 1, 2, . . . , ki and i = 1, 2, . . . , n. Also let z
∗
im = zim for m = 1, 2, . . . , ki − 1
and z∗iki = (1 − 2δi)ziki for i = 1, 2, . . . , n and N =
∑n
i=1 ki. Define X = (z
∗
im,m =
1, 2, . . . , ki, i = 1, 2, . . . , n)
′, which is a N × (2 + p) matrix for J = 1 or a N × (J + p)
matrix for J > 1. We are led to the following theorem.
Theorem 2.3.5. Suppose that X is of full rank, F is continuous, and 0 < F < 1. Then
the maximum likelihood estimates (MLE) of ψ = (ψ0, . . . , ψJ−1)′ and β under the ELTH
model exist if and only if there exists a N -dimensional positive vector a = (a1, . . . , aN )
′,
i.e., ai > 0 for i = 1, . . . , N , such that
X ′a = 0.
The proof of Theorem 2.3.5 directly follows from Theorem 3.1 in Chen and Shao (2001).
We now present a simply example to illustrate the results established in Theorem 2.3.5.
An Illustrative Example. We consider two small discrete survival datasets (denoted
by D1 and D2) with two covariates shown in Table 2.1. We note that these two datasets
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Table 2.1: Two small discrete survival data
Data i tki δi xi1 xi2
D1 1 1 1 0 0
(n = 3) 2 2 1 0 1
3 1 1 1 1
D2 1 1 1 0 0
(n = 4) 2 2 1 0 1
3 1 1 1 1
4 3 1 1 0
are two subsets of the SEER breast cancer data with covariates estrogen receptor status
(ER) and treatment indicators of surgery (Surg). Due to the small sample size, we assume
the piecewise baseline hazard model (2.25) for the αk with J = 1. For data D1, k1 = 1,
k2 = 2, k3 = 1, p = 2, z
∗
11 = −(1, 1, 0, 0)′, z∗21 = (1, 1, 0, 1)′, z∗22 = −(1, 2, 0, 1)′, and
z∗31 = −(1, 1, 1, 1)′. Thus, N = 4, and X is a 4× 4 matrix given by
X =

−1 −1 0 0
1 1 0 1
−1 −2 0 −1
−1 −1 −1 −1

. (2.27)
Since X is of full rank, only a = (0, 0, 0, 0)′ satisfies X ′a = 0. Therefore, the MLE
of (ψ0, ψ1, β1, β2) does not exist for data D1. For data D2, k1 = 1, k2 = 2, k3 = 1,
k4 = 3, p = 2, z
∗
11 = −(1, 1, 0, 0)′, z∗21 = (1, 1, 0, 1)′, z∗22 = −(1, 2, 0, 1)′, z∗31 = −(1, 1, 1, 1)′,
z∗41 = (1, 1, 1, 0)′, z∗42 = (1, 2, 1, 0)′, and z∗43 = −(1, 3, 1, 0)′. Thus, N = 7, and the
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corresponding matrix X is
X ′ =

−1 1 −1 −1 1 1 −1
−1 1 −2 −1 1 2 −3
0 0 0 −1 1 1 −1
0 1 −1 −1 0 0 0

.
It is easy to verify that (i) X is of full rank and (ii) a positive vector a = (3, 4, 1, 3, 1, 3, 1)′
satisfies X ′a = 0. Thus, the MLE of (ψ0, ψ1, β1, β2) exists for data D2.
2.3.8 Proposed Survival Models
We propose the following additive model for the discrete time survival function:
F−1
(
S(k|x,β)) = αk + x′β, (2.28)
where F is a continuous monotone increasing function and F−1 is the inverse function of
F . Throughout the paper, we assume 0 < F (u) < 1 for −∞ < u < ∞. Also, we assume
that αk is strictly decreasing in k, which restriction is different to the ELTH model in
(2.16). Unlikely to the link function, η in (2.14), we can directly use any cdf as a link
function by assuming F in (2.28) as a monotone increasing function. Let ak = F
−1(S0(k)),
then we can rewrite (2.28) as
exp
{
F−1
(
S(k|x,β))} = exp{F−1(S0(k))} exp (−x′β).
that model is attractive since it is a proportional baseline survival model. Thus, the
proposed model can be viewed as the proportional exponentiated link transformed sur-
vival (ELTS) model and αk is called the link transformed baseline survival function with
strictly monotone decreasing property in k. By taking F−1(u) = − log[− log(u)], which
is monotone increasing, Zhao and Zhou’s survival function in is reduced to (2.28) with
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αk = − log[− log(1 − θ + θSZ0 (k))], which is strictly decreasing function in k as SZ0 (k) is
strictly increasing function in k.
2.3.9 The Cure Rate under the ELTS Models
Theorem 2.3.6. Under the model (2.28), the survival function is improper iff limk→∞ αk =
c0, where c0 ∈ (−∞,∞).
Theorem 2.3.6 implies that the cure rate is S(∞|x) = F (c0 +x′β). Thus, the modeling
of baseline survival function is a key to estimate the cure rate accurately.
2.3.10 Modeling the Baseline Survival Functions
Similar to (2.24), the simplest baseline survival function is a linear model as follows
αk = η0 + η1tk, (2.29)
for η1 < 0 where tk is the survival time when the survival function S(k|x,β) is defined. The
key difference of αk in (2.29) compared to the model the model in (2.24) is the restriction
of negative linear coefficient, η1 < 0. Similar to (2.25), we extend the idea (2.29) and
propose a piecewise linear baseline survival model of αk. For that, we first construct a
finite partition of the interval [t1,∞), m0 = t1 < m1 < m2 < . . . < mJ−1 < mJ = ∞.
We consider standardized piecewise linear functions for αk for the first J − 1 intervals
and linear function for the last J using the monotone baseline B`(·) for ` = 1, . . . , J . To
construct decreasing function αk in k, we assume αk as a piecewise linear functions as
follows
αk =

η0 + η1tk if J = 1,
η0 +
∑J−1
`=1 η`B`(tk) + ηJ(tk −mJ−1)+ if J > 1,
(2.30)
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for η` < 0 for all ` = 1, . . . , J , where (tk − mJ−1)+ = tk − mJ−1 if tk > mJ−1 and 0
otherwise, and
B`(tk) =

0 if tk < m`−1,
tk−m`−1
m`−m`−1 if m`−1 ≤ tk < m`,
1 if tk > m`.
Under the 2.30, the baseline αk is continuous and for each piecewise intervals, the decreas-
ing slope is different. For example, at the `− 1 the interior knot, m`−1, the αk is
∑`−1
j=0 η`
and the slope of segment on the `−th interval [m`−1,m`) is η`m`−m`−1 . Since the restriction
of η` < 0 for all ` = 1, . . . , J in (2.30), we can consider nonlinear coefficient as follows
αk =

η0 − exp(η∗1)tk if J = 1,
η0 −
∑J−1
`=1 exp(η
∗
` )B`(tk)− exp(η∗J)(tk −mJ−1)+ if J > 1,
(2.31)
The attractive part of (2.31) is that there is no restriction for all η∗` ’s. Thus, the model in
(2.31) can reduce the computational complexity. We proposed piecewise constant for αk
for the first J − 1 intervals and linear for the last J interval in (2.25), which is different
the model for baseline survival function in (2.31) or (2.31). However, with same number
of intervals, J , the number of parameters for the αk are same.
Theorem 2.3.7. Under the model (2.31), S(∞|x,β) > 0 iff η∗J → −∞.
The proof of Theorem 2.3.7 is straight forward by Theorem 2.3.6.
2.3.11 Likelihood Function under ELTS Model
Suppose there are n subjects. For the i-th subject, let tki denote the discrete failure
time of i − th subject at time tki and let δi be the censoring indicator such that δi = 1
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if tki is the failure time and 0 otherwise. Let D = {(tki , δi, xi), i = 1, . . . , n} denote the
observed data. Then, the observed data likelihood function can be expressed as follows
L(β, S0|D) =
n∏
i=1
[Pr(Ti = tki |xi,β)]δi [Pr(Ti > tki |xi,β)]1−δi .
We can rewrite likelihood function as follows
L(β, S0|D) =
n∏
i=1
[S(ki − 1|xi,β)− S(ki|xi,β)]δi [S(ki|xi,β)]1−δi
=
n∏
i=1
[F (αki−1 + x
′β)− F (αki + x′β)]δi [F (αki − x′β)]1−δi . (2.32)
The form of the likelihood in 2.32 is analogues to the one for the ordinal data. Thus, the
likelihood function under the ELTS model is quite different than the one under the ELTH
model in section 2.3.6.
2.3.12 Model Comparison and Assessment
Under the piecewise baseline hazard model (2.25), the likelihood function L(β, h0|D)
in (2.26) is a function of (ψ,β). Thus, we rewrite L(ψ,β|D) = L(β, h0|D). Let (ψˆ, βˆ)
denote the MLE of (ψ,β). Then, AIC is given by
AIC = −2 logL(ψˆ, βˆ|D) + 2dim(ψ,β),
and BIC is defined as
BIC = AIC + (log n− 2)dim(ψ,β).
Similarly, under the piecewise baseline survival model (2.30) the likelihood function in
(2.32) is a function of (η,β) and L(η,β|D) = L(β, h0|D). Define the MLE of (η,β) as
(ηˆ, βˆ). Then, AIC and BIC are correspondingly given by
AIC = −2 logL(ηˆ, βˆ|D) + 2dim(η,β),
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and
BIC = AIC + (log n− 2)dim(η,β).
We examine the performance of AIC and BIC in determining the choice of links and
the number of pieces in the piecewise baseline hazard model (2.25) in a simulation study
and we also use AIC and BIC to select the best model to fit the SEER breast cancer data
in Chapter 3.
Chapter 3
Simulation Study and Data analysis
3.1 Simulation Studies
3.1.1 The Simulation Study under ELTH Model
We conduct two simulation studies as follows. For each simulated dataset of size n,
we first generate xi = (x1i, x2i)
′ as x1i ∼ N(0, 1) and x2i|x1i ∼ Bernoulli(qi), where
qi = exp(0.1 − 0.1x1i)/{1 + exp(0.1 − 0.1x1i)}. We then use the inverse cdf approach to
generate the discrete survival time Ti from the ELTH model (2.17) under the logit link
along with the linear baseline hazard model (2.24) for the αk with ψ = (−2.7,−0.03)′
and β = (0.5, 0.5)′ (Simulation I) or the piecewise baseline hazard model (2.25) for the
αk with J = 5, (s1, s2, s3, s4) = (3, 6, 10, 22), ψ = (−3.5, 0.2, 0.35, 0.05,−0.01)′, and β =
(0.5, 0.5)′ (Simulation II). The censoring time Ci is generated uniformly from a discrete
set {1, 2, . . . , 85} (Simulation I) or {1, 2, . . . , 100} (Simulation II). Finally the observed
discrete survival time is tki = min{Ti, Ci} and the censoring indicator δi = I{Ti ≤ Ci}
for i = 1, . . . , n. In both simulation studies, we generate 1,000 simulated datasets with
n = 1000 or n = 2000. Under the above settings, the average percentage of censored
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observations is about 26% and all of the average hazards are less than 0.09 across 1000
simulated datasets.
In Simulation I, for each simulated dataset, we fit the Cox proportional hazards model
by treating the discrete time survival data as the continuous survival time data and com-
pute the MLEs of β and the corresponding standard errors and 95% confidence intervals
(CI’s) under the true model as well as the Cox model; and we also fit the ELTH models
under the logit (true), C-log-log, probit, and t4 links and compute AIC and BIC for each
of the four ELTH models. In Simulation II, for each simulated dataset, we fit the four
ELTH models with J = 5 as in Simulation I and compute AIC and BIC for each model;
and we also fit the ELTH models under the logit link for J = 1, J = 5 (true), J = 10, and
J = 15 and again compute AIC and BIC for each J .
Results of Simulation I. Table 3.1 shows the means of estimates (EST’s), the averages
of standard errors (ASE’s), the simulation standard deviations of estimates (SSD’s), the
roots of mean squared errors (RMSE’s), and the coverage probabilities (CP’s) of 95%
confidence intervals for β1 and β2 under the ELTH and Cox models.
We see from Table 3.1 that (i) under the ELTH model with the true logit link, the
estimates of β were very close to the true values, the SSD and ASE were almost the same
for each of β1 and β2, both the SSD and ASE decreased when n increases, and the CPs
were close to 95%; (ii) the estimates of β under the ELTH model with the C-log-log link
were much better than those under ELTH models with the probit and t4 links and the
CP’s were 0 under the ELTH model with the probit link; and (iii) under the Cox model,
the estimates were biased, the biases increased when n increases, and the CP’s were much
smaller than 95%. We note that the differences in the estimates between the logit and
33
Table 3.1: Estimates of β under the ELTH and Cox models
n Parameter Model EST ASE SSD RMSE CP
1000
β1 = 0.5
Logit (true) 0.499 0.041 0.040 0.040 0.951
C-log-log 0.479 0.039 0.038 0.044 0.924
Probit 0.238 0.020 0.019 0.263 0
t4 0.402 0.033 0.033 0.103 0.149
Cox 0.459 0.039 0.036 0.055 0.820
β2 = 0.5
Logit (true) 0.498 0.077 0.079 0.079 0.947
C-log-log 0.478 0.074 0.076 0.079 0.936
Probit 0.236 0.036 0.038 0.266 0
t4 0.402 0.063 0.064 0.117 0.658
Cox 0.459 0.074 0.073 0.083 0.920
2000
β1 = 0.5
Logit (true) 0.501 0.029 0.029 0.029 0.949
C-log-log 0.480 0.027 0.027 0.034 0.887
Probit 0.238 0.014 0.014 0.262 0
t4 0.403 0.023 0.023 0.100 0.021
Cox 0.460 0.027 0.026 0.047 0.696
β2 = 0.5
Logit (true) 0.500 0.055 0.055 0.055 0.955
C-log-log 0.480 0.052 0.053 0.056 0.931
Probit 0.238 0.026 0.026 0.264 0
t4 0.404 0.045 0.045 0.106 0.418
Cox 0.462 0.052 0.051 0.064 0.889
C-log-log links might be due to the fact that the average hazards of less than 0.09 might
not be smaller enough.
Table 3.2: Estimates of β under the ELTH models with logit and C-log-log links for the
simulation study with the average hazards ≤ 0.07 across 1000 simulated datasets
n Parameter Model EST ASE SSD RMSE CP
1000
β1 = 0.2
Logit (true) 0.198 0.039 0.038 0.038 0.948
C-log-log 0.193 0.037 0.037 0.038 0.943
β2 = 0.2
Logit (true) 0.197 0.076 0.080 0.080 0.946
C-log-log 0.191 0.074 0.078 0.078 0.941
2000
β1 = 0.2
Logit (true) 0.200 0.027 0.027 0.027 0.949
C-log-log 0.195 0.026 0.026 0.027 0.941
β2 = 0.2
Logit (true) 0.201 0.054 0.054 0.054 0.949
C-log-log 0.196 0.053 0.053 0.053 0.941
To examine this issue, we generated the discrete survival data with β = (0.2, 0.2)′ and
β = (0.02, 0.02)′ under the ELTH model with the logit link, which yielded the average
hazards less than 0.07 and 0.062 across 1000 simulated datasets, respectively. respectively.
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Table 3.3: Estimates of β under the ELTH models with logit and C-log-log links for the
simulation study with the average hazards ≤ 0.062 across 1000 simulated datasets
n Parameter Model EST ASE SSD RMSE CP
1000
β1 = 0.02
Logit (true) 0.017 0.039 0.038 0.038 0.951
C-log-log 0.017 0.038 0.037 0.037 0.951
β2 = 0.02
Logit (true) 0.016 0.077 0.081 0.081 0.945
C-log-log 0.016 0.075 0.079 0.079 0.945
2000
β1 = 0.02
Logit (true) 0.020 0.027 0.027 0.027 0.954
C-log-log 0.020 0.027 0.027 0.027 0.957
β2 = 0.02
Logit (true) 0.021 0.055 0.055 0.055 0.949
C-log-log 0.021 0.053 0.054 0.054 0.949
These additional simulation results are given in Tables 3.2 and 3.3. From these two tables,
we now see that the estimates from the C-log-log link were almost the same as those from
the true logit link. These results suggest that (i) the estimates under the ELTH model
with the C-log-log link are similar to those under the ELTH model with the logit link when
the hazards are small although one is an asymmetric link while another link is symmetric;
(ii) the ELTH models with probit and t4 links fit the discrete survival data generated from
the ELTH model with the logit link poorly; and (iii) fitting the discrete time survival data
as the continuous time survival data can lead to a substantial bias in the estimation of
regression coefficients.
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Figure 3.1: Boxplots of AIC difference between each of the C-log-log, probit, and t4 links
and the logit link with the linear baseline hazard for αk for n = 1000 and n = 2000.
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The boxplots in Figure 3.1 show the AIC differences between the ELTH models with
the C-log-log, probit, and t4 links and the true ELTH model with the logit link. Note that
the BIC differences are exactly the same as the AIC differences in this case. The mean
AIC differences were 0.10 and 0.17 between the C-log-log and logit links, 1.18 and 2.76
between the probit and logit links, and 1.64 and 3.02 between the t4 and logit links for
n = 1000 and n = 2000, respectively. Over 78% and 79% of the AIC differences between
the probit and logit links and between the t4 and logit links were above 0 for n = 2000.
The AIC differences between the C-log-log and logit links were not noticeable, which
empirically confirms our Empirical Observation. As discussed in Section 2.3.1, the discrete
time hazard is the one under the ELTH with the C-log-log link if the data are generated
from the continuous time Cox model. Therefore, ignoring the discreteness of observed
survival data will lead to biased estimates of regression coefficients. We also note that if
F1(u) = exp(u)/{1 + exp(u)}, then lim
u→−∞[F1(c1u + c2)/Φ(u)] = ∞ and limu→−∞[F1(c1u +
c2)/Ft4(u)] = 0 for any c1 > 0 and c2, where Φ and Ft4 denote the N(0, 1) and t4 cdf’s.
This explains the reason why the ELTH models with the probit and t4 links did not fit
well to the data generated under the logit link.
Results of Simulation II.
Table 3.4: Means of AIC and BIC differences and frequencies of ranking each model as
best based on AIC and BIC
AIC BIC
n = 1000 n = 2000 n = 1000 n = 2000
Mean Frequency Mean Frequency Mean Frequency Mean Frequency
J = 1 6012.7 151 12011.1 29 6032.3 912 12033.5 594
J = 5 6006.7 766 11995.7 849 6041.1 88 12034.9 406
J = 10 6011.9 66 12000.6 91 6070.0 0 12067.3 0
J = 15 6016.5 17 12004.9 31 6098.9 0 12099.5 0
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The means of AIC’s and BIC’s and frequencies of ranking each model as best for the
four ELTH models corresponding to J = 1, 5, 10, and 15 under the logit link are reported
in Table 3.4.
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Figure 3.2: Boxplots of AIC difference between each of the C-log-log, probit, and t4 links
and the logit link with the piecewise baseline hazard for αk with J = 5 for n = 1000 and
n = 2000.
The boxplots of the AIC and BIC differences between each of J = 1, 10, 15 and J = 5
(true) are shown in Figure 3.2. From Table 3.4, we see that the true model with J = 5 had
the smallest means of AIC, while the ELTH model with J = 1 had the smallest means
of BIC; and AIC selected the true model 766 and 849 times out of 1000 simulations,
corresponding to 76.6% and 84.9% powers, for n = 1000 and n = 2000, respectively, while
BIC selected the true model only 88 and 406 times out of 1000 simulations for n = 1000
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and n = 2000, respectively. These results are not surprising since BIC penalizes the
dimension more severely than AIC. From Figure 3.2, we see that all of the three boxes in
Plot (a) or Plot (b) are above 0 while the whole box for J = 1 in Plot (c) and more than
half of the box for J = 1 in Plot (d) are below 0. The findings from these boxplots are
consistent with those in Table 3.4.
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Figure 3.3: Boxplots of AIC difference between each of the C-log-log, probit, and t4 links
and the logit link with the piecewise baseline hazard for αk with J = 5 for n = 1000 and
n = 2000.
Similar to Simulation I, we also compare the ELTH models with four different links
for the piecewise baseline hazard with J = 5. Figure 3.3 shows the boxplots of AIC
differences between the C-log-log, probit, and t4 links and the true logit link. Again, the
BIC differences are exactly the same as the AIC differences when we only compare the
different links for a given value of J . The boxplots in this figure are very similar to those
in 3.1.
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3.2 Analysis of the SEER Breast Cancer Data
3.2.1 Data Analysis under the ELTH Model
We first obtain the maximum likelihood estimates (ESTs), the standard errors (SEs),
and the p-values of the parameters under the ELTH models with linear αk given in (2.24)
under the logit, C-log-log, probit, t4, and standard Laplace links.
Table 3.5: Estimates of the parameters under the ELTH models for J = 1 for the SEER
breast cancer data
Logit Link C-log-log Link
Variable EST SE P value EST SE P-value
Intercept -5.092 0.387 <0.001 -5.094 0.385 <0.001
Size 0.002 0.001 0.042 0.002 0.001 0.042
Ext 0.010 0.003 <0.001 0.010 0.003 <0.001
PN -0.507 0.106 <0.001 -0.505 0.106 <0.001
ER -0.570 0.147 <0.001 -0.568 0.146 <0.001
PR -0.191 0.151 0.205 -0.191 0.150 0.204
grade -0.271 0.218 0.214 -0.270 0.217 0.214
race -0.279 0.130 0.031 -0.279 0.129 0.031
Surg -0.654 0.216 0.003 -0.654 0.214 0.002
Rad -0.630 0.107 <0.001 -0.628 0.107 <0.001
age 0.024 0.004 <0.001 0.024 0.003 <0.001
time -0.014 0.002 <0.001 -0.014 0.002 <0.001
Probit Link t4 Link
Intercept -2.496 0.137 <0.001 -4.476 0.483 <0.001
Size 0.001 0.0003 0.051 0.003 0.001 0.027
Ext 0.004 0.001 <0.001 0.014 0.003 <0.001
PN -0.170 0.035 <0.001 -0.662 0.147 <0.001
ER -0.188 0.049 <0.001 -0.775 0.195 <0.001
PR -0.057 0.050 0.256 -0.312 0.207 0.133
grade -0.097 0.073 0.186 -0.300 0.290 0.301
race -0.095 0.045 0.032 -0.356 0.163 0.029
Surg -0.224 0.083 0.007 -0.825 0.222 <0.001
Rad -0.212 0.036 <0.001 -0.821 0.150 <0.001
age 0.008 0.001 <0.001 0.033 0.005 <0.001
time -0.004 0.001 <0.001 -0.023 0.003 <0.001
The results are given in Table 3.5 and 3.6. From Tables 3.5 and 3.6, we observe that
(i) the estimates and p-values under the logit and C-log-log links are almost the same and
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Table 3.6: Estimates of the parameters under the standard Laplace link for J = 1 and
(J, J∗) = (35, 5) for the SEER breast cancer data
J = 1 J = 35, J∗ = 5
Variable EST SE P value Variable EST SE P value
Intercept -4.4045 0.383 <.001 Intercept -5.103 0.404 <.001
Size 0.002 0.001 0.041 Size 0.002 0.001 0.048
Ext 0.010 0.003 <.001 Ext 0.010 0.003 <.001
PN -0.504 0.106 <.001 PN -0.499 0.105 <.001
ER -0.567 0.146 <.001 ER -0.555 0.145 <.001
PR -0.191 0.150 0.202 PR -0.173 0.149 0.247
grade -0.269 0.216 0.214 grade -0.276 0.215 0.201
race -0.278 0.129 0.030 race -0.272 0.128 0.034
Surg -0.653 0.213 0.002 Surg -0.626 0.212 0.003
Rad -0.626 0.106 <.001 Rad -0.618 0.106 <.001
age 0.024 0.004 <.001 age 0.024 0.004 <.001
time -0.014 0.002 <.001 (t− s29)+ -0.019 0.008 0.015
those under the probit and t4 links are different; (ii) the difference between the estimates for
intercept under the C-log-log and standard Laplace link is approximately log(2); and (iii)
the “time” variable is highly significant and the estimate of the corresponding coefficient
ψ1 is less than 0 under all the five links. The first two results are the direct consequences of
our Empirical Observation and the third result implies that the data are from a population
with a cure fraction of breast cancer according to Theorem 2.3.4.
To determine the choice of links and the piecewise baseline hazard model (2.25), we
first fit the ELTH models with logit, C-log-log, probit, and t4 links for various values of
J to the SEER breast cancer data. Table 3.7 shows the values of AIC and BIC by fitting
the ELTH models with piecewise baseline hazards under the above four links. We observe
that (i) the smallest AIC value is achieved at J = 35 under each of the four links; (ii)
the t4 link yields the smallest values of AIC and BIC; (iii) the ELTH model with J = 35
has the smallest BIC value for logit, C-log-log, and t4 links while the ELTH model with
J = 30 has the smallest BIC value under the probit link; and (iv) the ELTH model with
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Table 3.7: AICs and BICs for the SEER breast cancer data under the ELTH mdoel
J Link Log-likelihood AIC BIC
1 Logit -2492.48 5008.96 5076.74
C-log-log -2492.33 5008.66 5076.44
Probit -2497.65 5019.30 5087.07
t4 -2492.18 5008.36 5076.13
15 Logit -2368.99 4787.99 4929.18
C-log-log -2368.83 4787.65 4928.85
Probit -2373.53 4797.07 4938.26
t4 -2363.71 4777.42 4918.62
30 Logit -2281.89 4643.78 4869.69
C-log-log -2281.81 4643.62 4869.54
Probit -2283.95 4647.90 4873.81
t4 -2281.64 4643.29 4869.20
35 Logit -2262.10 4614.21 4868.36
C-log-log -2261.98 4613.96 4868.11
Probit -2265.13 4620.26 4874.41
t4 -2260.64 4611.28 4865.43
40 Logit -2260.65 4617.31 4888.40
C-log-log -2260.54 4617.09 4888.18
Probit -2263.55 4623.09 4894.18
t4 -2259.39 4614.77 4885.87
J = 35 fits the data much better than the one with J = 1. From Table 3.7, we see that the
values of AIC and BIC under the t4 link are 4611.28 and 4865.43 for J = 35 and 5008.36
and 5076.13 for J = 1, respectively, and the results under other three links are similar.
Since the right tail portion of the hazard function is typically more flat than the portion
at earlier time, it is expected that the right tail of the hazard should be more parsimonious.
Thus, the second stage of our selection procedure for αk is to further reduce the number
of pieces from the right tail of the hazard in (2.25) under the “best” ELTH models with
J = 35. Specifically, instead of (2.25), we consider
αk = ψ0 +
J−2−J∗∑
j=1
ψj I{sj ≤ tk < sj+1}+ ψJ−1−J∗(tk − sJ−1−J∗)+, (3.1)
where J∗ ≥ 0 such that J − 1− J∗ > 0. We note that (3.1) with J∗ = 0 reduces to (2.25)
and a larger value of J∗ yields a more parsimonious model. We choose the value of J∗
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Table 3.8: AICs and BICs for reduction of the number of pieces for the piecewise baseline
hazard under the ELTH model with J = 35
J∗ Link Log-likelihood AIC BIC
1 Logit -2264.06 4616.12 4864.62
C-log-log -2263.95 4615.89 4864.39
Probit -2266.84 4621.68 4870.19
t4 -2262.98 4613.96 4862.46
3 Logit -2263.57 4611.15 4848.36
C-log-log -2263.46 4610.91 4848.12
Probit -2266.52 4617.04 4854.25
t4 -2262.29 4608.58 4845.78
5 Logit -2265.42 4610.85 4836.76
C-log-log -2265.29 4610.57 4836.48
Probit -2269.13 4618.26 4844.17
t4 -2262.87 4605.74 4831.65
6 Logit -2269.64 4617.27 4837.54
C-log-log -2269.48 4616.96 4837.22
Probit -2273.95 4625.89 4846.16
t4 -2265.73 4609.46 4829.73
8 Logit -2285.29 4642.59 4845.91
C-log-log -2285.14 4642.28 4845.60
Probit -2289.51 4651.01 4854.33
t4 -2282.11 4636.22 4839.54
according to the AIC or BIC criterion. Table 3.8 shows the AIC values for various choices
of J∗. We see from Table 3.8 that the smallest AIC value is obtained at J∗ = 5 under
the logit, C-log-log, and t4 links. Under the logit, C-log-log, probit, and t4 links, the AIC
values are 4610.85, 4610.57, 4618.26, and 4605.74, respectively, for J∗ = 5, and 4614.21,
4613.96, 4620.26, and 4611.28, respectively, for J∗ = 0. Similarly, the BIC value is also
minimized at J∗ = 5 for the logit, C-log-log, and probit links. In the remaining of the
analysis of the SEER breast cancer data, we use αk in (3.1) with J = 35 and J
∗ = 5.
The maximum likelihood estimates (ESTs), the standard errors (SEs), and the p-values
of the parameters under the ELTH models with J = 35 and J∗ = 5 are reported in Table
3.9.
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Table 3.9: Estimates of the parameters under the ELTH models for J = 35 and J∗ = 5
for the SEER breast cancer data
Logit Link C-log-log Link
Variable EST SE P value EST SE P value
Intercept -5.791 0.411 < 0.001 -5.794 0.408 < 0.001
Size 0.002 0.001 0.050 0.002 0.0010 0.049
Ext 0.010 0.003 < 0.001 0.010 0.003 < 0.001
PN -0.505 0.106 < 0.001 -0.502 0.106 < 0.001
ER -0.561 0.147 < 0.001 -0.558 0.146 < 0.001
PR -0.172 0.151 0.255 -0.172 0.150 0.251
grade -0.278 0.218 0.203 -0.277 0.217 0.202
race -0.274 0.130 0.036 -0.273 0.129 0.035
Surg -0.634 0.218 0.004 -0.630 0.215 0.003
Rad -0.626 0.107 < 0.001 -0.622 0.107 < 0.001
age 0.024 0.004 < 0.001 0.024 0.004 < 0.001
(t− s29)+ -0.019 0.008 0.015 -0.019 0.008 0.015
Probit Link t4 Link
Intercept -2.720 0.152 < 0.001 -5.335 0.477 < 0.001
Size 0.001 0.0004 0.067 0.002 0.001 0.039
Ext 0.004 0.001 < 0.001 0.011 0.003 < 0.001
PN -0.180 0.038 < 0.001 -0.578 0.129 < 0.001
ER -0.192 0.053 < 0.001 -0.684 0.173 < 0.001
PR -0.049 0.053 0.357 -0.272 0.184 0.140
grade -0.108 0.078 0.168 -0.286 0.255 0.262
race -0.099 0.048 0.038 -0.309 0.146 0.035
Surg -0.240 0.089 0.007 -0.679 0.206 < 0.001
Rad -0.226 0.038 < 0.001 -0.707 0.132 < 0.001
age 0.009 0.001 < 0.001 0.029 0.004 < 0.001
(t− s29)+ -0.005 0.002 0.031 -0.042 0.014 0.004
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The results under the standard Laplace link are given in Table 3.6. The results for
J = 35 and J∗ = 5 are similar to those in Table 3.6. The estimates of β and the p-values
under the logit are very close to those under the C-log-log link, which is expected according
to our Empirical Observation. The time term, (t − s29)+, is significant, with a p-value
ranging from 0.004 to 0.031, and the estimate of the corresponding coefficient is negative
under all five links, indicating the cure fraction of the breast cancer data.
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Figure 3.4: Boxplots of the estimated cure rates stratified by treatment (surgery and
radiation, only surgery, and others).
Under the ELTH model with the t4 link, J = 35, and J
∗ = 5, we compute the estimated
cure rates of S(∞|x,β) and Figure 3.4 shows the boxplots of these estimates stratified by
the three treatment groups (surgery and radiation, only surgery, and other). Here, “only
surgery” refers to “surgery without radiation” and a patient who had surgery might also
receive treatments other than radiation.
A summary of these cure rates is given in Table 3.10. From Figure 3.4, we see that
patients treated by both surgery and radiation clearly had higher cure rates than those
treated by only surgery or other while patients treated by other had the lowest cure
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Table 3.10: A summary of estimated cure rates under the t4 link and the corresponding
values of covariates for the SEER breast cancer data
Treatment Cure Rate
Corresponding Covariates
Size Ext PN ER PR grade race age
Surg+Rad
Maximum: 0.920 59 11 1 1 1 1 1 23
Q3: 0.847 100 16 0 1 1 1 1 46
Median: 0.805 34 50 1 1 1 1 1 74
Q1 : 0.744 130 11 0 1 1 1 1 79
Minimum: 0.320 65 50 0 0 0 1 0 84
Surg
Maximum: 0.888 29 10 1 1 1 1 1 27
Q3 : 0.751 15 10 0 1 1 1 0 51
Median: 0.665 90 30 1 1 0 0 1 67
Q1 : 0.538 18 10 1 0 0 0 1 75
Minimum: 0.012 60 40 0 0 0 0 0 98
Other
Maximum: 0.828 37 40 1 1 1 1 1 46
Q3 : 0.489 50 50 0 1 0 1 1 78
Median: 0.421 60 60 0 1 1 1 1 66
Q1 : 0.250 10 10 0 0 0 1 1 73
Minimum: 0.016 70 50 0 0 0 1 0 78
rates. For those patients who treated by both surgery and radiation, the minimum and
maximum of the cure rates are 0.32 and 0.92 and the corresponding values of the covariate
vector (Size, Ext, PN, ER, PR, grade, race, age) are (65, 50, 0,0,0,1,0,84) and (59, 11,
1,1,1,1,1,23), respectively. The information for other two treatment groups can be found
in Table 3.10. The patient who had the worst cure rate of 0.012 in our study cohort was
98 years old with grade IV breast cancer, treated by only surgery, and had a more than 6
of highest involved positive lymph nodes and negative estrogen and progesterone statuses.
On the other hand side, the patient who had the highest cure rate of 0.92 was 23 years
old with grade III breast cancer, and had a low number of highest involved positive lymph
nodes and positive estrogen and progesterone statuses. These results are quite reasonable
and clinically justifiable.
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Table 3.11: Estimates of the parameters under Cox models for the SEER breast cancer
data
Variable EST SE P value
Size 0.001 0.001 0.025
Ext 0.007 0.001 <.001
PN -0.473 0.059 <.001
ER -0.357 0.082 < .001
PR -0.084 0.082 0.304
grade -0.171 0.125 0.172
race -0.334 0.073 <.001
Surg -0.559 0.139 <.001
Rad -0.436 0.060 <.001
age 0.020 0.002 <.001
In addition, Table 3.11 shows the estimates of the parameters under the Cox regression
model treating the discrete time survival data as the continuous survival time data. Com-
pared Table 3.11 to Table 3.9, we see some differences in the estimates of the parameters.
Specifically, Size and race under the Cox model are more significant than those under the
the ELTH models. Based on our simulation study, the estimates under the Cox model
could be biased.
Chapter 4
A New Method for Estimating the True Survival Function
for Mismeasured Data
4.1 Introduction
A centerpiece in the practice of medicine requires accuracy in the diagnosis of disease.
Nonetheless, errors in disease diagnosis do occur, which may lead to disease outcomes
that are incorrectly measured. Misclassification of a disease outcome can occur from
diagnostic test results being false negative or false positive. The integrity of clinical trials
depends on accurate measures of disease status. In many clinical trials, of importance is
the time to the first event such as viral negativity in virology, or progression-free survival
in oncology. Furthermore, in radiology, misclassification could result due to discordance
in image findings between the central and investigator review. In virology, an error in the
diagnosis of viral negativity could take place due to the insensitivity of the assay to low
viral levels; this type of measurement error is actually due to limit detection.
If we apply standard survival methods, which assumes there is no misclassified out-
comes, to the survival data with mismeasured outcomes, then the estimates can be biased.
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Many authors have discussed about this issue and developed methods for that. However,
most of the methods are for the continuous time survival data.
We develop a new method to estimate the (true) survival function when the diagnostic
tool used to measure the outcome of disease is error-prone outcome. We assume the true
or error-free outcome is latent since the diagnostic tool used to measure disease outcome
is not the gold standard. The new method connects the error prone outcomes to the
true outcomes by modeling time varying negative predicted value (NPV) and the positive
predictive values (PPV).
4.2 The Methods
4.2.1 The Hazards for Mismeasured and True Discrete Survival Times
The design of this study builds on the notion that there exist two populations of events,
(i) the population of potentially mismeasured (error-prone) events and (ii) the population
of true (latent) events. As a result of the use of an imperfect diagnostic test or procedure,
the events in (i) are subject to be observed with error; while the events in (ii) are latent,
the use of an error prone diagnostic test renders the true statuses of these events to be
unobservable. The rest of this section provides notation for the observed and true hazards
as well as their respective survival functions.
Define T to be a discrete random variable taking only positive values 0 < t1 < t2 < · · · .
We assume that T is observable but may be mismeasured. The discrete time hazard
function for T at time tj is defined as
h(j) = P (T = tj |T ≥ tj). (4.1)
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Using (4.1), we have the probability of T at time tj as, P (T = tj) = h(j)
∏j−1
k=1{1−h(k)},
and the potentially mismeasured survival function as
S(j) = P (T > tj) =
j∏
k=1
{1− h(k)},
for j = 1, 2, . . . . Next, we discuss the basic formulation of the true hazard and survival
functions.
Let T ∗ be a true (latent) discrete random variable taking positive values 0 < t1 < t2 <
. . . . The true discrete time hazard function at tj for T
∗ is defined as
h∗(j) = P (T ∗ = tj |T ∗ ≥ tj),
for j = 1, 2, . . . . In a similar fashion to the observed survival time (S(j)), the proba-
bility of T ∗ at time tj is
P (T ∗ = tj) = h∗(j)
j−1∏
k=1
{1− h∗(k)},
therefore, the true survival function is
S∗(j) = P (T ∗ > tj) =
j∏
k=1
{1− h∗(k)}.
For the error prone population, let Ej = I(T = tj); for the true population, let
E∗j = I(T
∗ = tj) for j = 1, 2, . . . . Under this notation, the observed probability at time tj
is P (T > tj) = P (Ej = 0) while the true probability at time tj is P (T
∗ = tj) = P (E∗j = 1).
In our framework once an individual is observed to have an event the individual is no longer
followed, therefore, if Ej = 0 then Ek = 0 for k < j. Define γj as the negative predicted
value (NPV) and τj as the positive predicted value (PPV) at time tj , are given by
γj = P (T
∗ > tj |T > tj) and τj = P (T ∗ ≤ tj |T ≤ tj), (4.2)
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for j = 1, 2, . . . .
Remark 4.1: Under our notation we have the following relationships,
(i) S(j) = P (Ej = 0); S
∗(j) = P (E∗j = 0) are the probabilities of no event (survival);
(ii) P (T = tj) = P (Ej = 1); P (T
∗ = tj) = P (E∗j = 1) are the probabilities of an event;
(iii) γj = P (E
∗
j = 0|Ej = 0) is the NPV; and
(iv) τj = 1−
∑j
k=1 P (E
∗
j=0|Ek=1)P (Ek=1)
1−P (Ej=0) is the PPV.
4.2.2 Assumptions and Proposed Methods
The main goal of our paper is to develop a link between the true and error-prone (observed)
populations of events which will allow for the accurate estimation of the true survival
function. We formulate an exact relationship between the true and the observed survival
functions by the use of NPV and PPV of the diagnostic tool under complete dataset,
Lemma 4.2.1 provides details.
Lemma 4.2.1. The true survival function can be expressed as
S∗(j) = P (E∗j = 0) = (1− τj){1− S(j)}+ γjS(j).
If the true outcomes are not latent, the above formula provides the exact relationship
between the true survival, S∗(j), and the observed survival, S(j). However, since the true
event is latent, we develop a new method to estimate true survival function using Lemma
4.2.1 by modeling NPV and PPV. Adeniji et al. (2014) proposed a method to estimate
true survival function using a constant NPV and PPV, however, we shall extend their
methods by allowing time-varying NPV and PPV.
Lemma 4.2.1 shows the importance of obtaining accurate measures of τj and γj in
order to obtain an unbiased estimate of the true survival function; therefore we calibrate
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the NPV and PPV by proposing a relationship between the true and observed events. To
obtain the model of time-varying NPV and PPV, we develop two models of conditional
probabilities of true survival time given observed survival time as follows. For a known
τ0 and γ0, and for tk ≤ tj , we propose that (i) the probability of the occurrence of a true
failure by time tj , given an observed failure at a specified time tk is
P (T ∗ ≤ tj |T = tk) = 1− P (E∗j = 0|Ek = 1) = 1−
{
1− τ0
}(tj−t1)ω1+(tj−tk)ω2+1, (4.3)
where ω1 ≥ 0, ω2 ≥ 0, and 0 ≤ τ0 ≤ 1; and (ii) the probability of the occurrence of a true
failure at time tk prior to the observed failure by time tj is
P (T ∗ = tk|T > tj) = P (E∗k = 1|Ej = 0) =
{
1− γ0
}(tj−tk)ϕ2+1
jϕ1
, (4.4)
where ϕ1 ≥ 0 and ϕ2 ≥ 0, and 0 ≤ γ0 ≤ 1. The proposed models imply (i) the probability
of a true failure, given the prior occurrence of an observed failure, increases as the true
time moves further away from the observed time (4.3); and (ii) the probability of a true
failure occurring prior to the given observed non-failure, decreases as the true time moves
further away from the observed time (4.4). Using (4.3) and (4.4), we obtain the formula
for PPV and NPV in the following propositions.
Proposition 4.2.2. Under (4.3) and a known τ0 we have the following:
(i) if P (E1 = 1) > 0, the conditional probability of true failure time at t1 given observed
failure time at t1 is P (E
∗
1 = 1|E1 = 1) = P (T ∗ = t1|T = t1) = τ0;
(ii) The PPV at time tj is 1−
∑j
k=1 P (Ek=1)
{
1−τ0
}(tj−t1)ω1+(tj−tk)w2+1
1−P (Ej=0) ;
(iii) if ω2 = 0 then P (T
∗ ≤ tj |T = tk) is constant for all tk such that tk ≤ tj and PPV at
time tj is given as 1−
{
1− τ0
}(tj−t1)ω1+1; and
(iv) if ω1 = 0 and ω2 = 0 then for all tk such that tk ≤ tj and for any tj , P (T ∗ ≤ tj |T = tk)
and PPV at time tj are constant with a value of τ0.
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Proposition 4.2.3. Under (4.4) and a known γ0 we have the following:
(i) if P (E1 = 0) > 0, the probability of a true non-event given an observed non-event at
t1 is P (E
∗
1 = 0|E1 = 0) = 1− P (T ∗ = t1|T > t1) = γ0;
(ii) the NPV at time tj is γj = 1− 1jϕ1
∑j
k=1{1− γ0}(tj−tk)ϕ2+1;
(iii) if ϕ2 = 0, then P (T
∗ = tk|T > tj) is constant for all tk such that tk ≤ tj and NPV at
time tj is given as γj = 1− 1−γ0jϕ1−1 ; and
(iv) if ϕ1 = 1 and ϕ2 = 0, then NPV at any time tj is constant with a value of γ0, that is,
γj = γ0 for all j = 1, 2, . . . .
In order to advance towards the goal of obtaining the true (latent) survival function as
formulations of the observed (error-prone) survival, NPV and PPV, we make 2 assump-
tions; Assumption 1 and Assumption 2 form the basis of Theorem 4.2.5 and Theorem
5.4.2, respectively.
Assumption 4.1: The true event does not happen before the observed event. That is,
P (T ∗ ≥ T ) = 1.
For mismeasurement that are due to lower detection limit, Assumption 4.1 is especially rea-
sonable; we will further elaborate with the application of our methods to the VIRAHEP-C
data.
Proposition 4.2.4. Under Assumption 4.1, we have that (i) the NPV at time tj is
γj = P (E
∗
j = 0|Ej = 0) = 1 for all j = 1, 2, . . . ; and (ii) the PPV at time tj is τj =
1−P (E∗j=0)
1−P (Ej=0) , j = 1, 2, . . . .
Under the aforementioned assumption, the formula below provides a way to obtain the
true survival, S∗(j), from the observed survival, S(j).
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Theorem 4.2.5. Under Assumptions 4.1, the true survival function is given by
S∗(j) = S(j) +
j∑
k=1
P (Ek = 1)
{
1− τ0
}(tj−t1)ω1+(tj−tk)ω2+1, j = 1, 2, . . . .
The proof of Theorem 4.2.5 directly follows from Lemma 4.2.1, (i) of Proposition 4.2.4,
and (ii) of Proposition 4.2.2.
Within the survival framework, we wish to eventually express Theorem 4.2.5 in terms
of survival rates. However, our next step is to express this in terms of non-events. The
observed probability of having an event by time tk, P (Ek = 1), can be expressed as the
probabilities of non-events, namely,
P (Ek = 1) = P (Ek−1 = 0)− P (Ek = 0), (4.5)
for k = 1, 2, . . . . Note that the probability of a non-event prior to the start of the clinical
study is 1, hence, P (E0 = 0) = 1. Using (4.5), we express Theorem 4.2.5 in terms of
probability of non-events as,
S∗(j) = (1− τ0)(tj−t1)ω1+(tj−t1)ω2+1 + P (Ej = 0){1− (1− τ0)(tj−t1)ω1+1}
+
j−1∑
k=1
P (Ek = 0)(1− τ0)(tj−t1)ω1+(tj−tk+1)ω2+1{1− (1− τ0)(tk+1−tk)ω2}, (4.6)
where
∑0
k=1 P (Ek = 0)(1 − τ0)(tj−t1)ω1+(tj−tk+1)ω2+1{1 − (1 − τ0)(tk+1−tk)ω2} = 0. We
have now expressed Theorem 4.2.5 as a linear combination of PPV and probabilities of
non-events. Our next step is to express (4.6) in terms of PPV and the observed (error-
prone) survival vector. Let S∗(j)(S(j)) denote the true (observed) survival rate of the
true (observed) survival time at tj , for j ∈ {1, 2, . . . ,K}. Also, define the error prone
survival vector P0 = (S(1), S(2), . . . , S(K))T for time points 1 to K. We formulate (4.6)
as a function of PPV and the error prone survival vector P0 as follows
S∗(j) = fj + gTj P0, (4.7)
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where fj = (1− τ0)(tj−t1)ω1+(tj−t1)ω2+1, and gj = (gj1, gj2, . . . , gjK)T with
gjk =

{1− (1− τ0)(tk+1−tk)ω2}(1− τ0)(tj−t1)ω1+(tj−tk+1)ω2+1 for k = 1, . . . , j − 1
1− (1− τ0)(tj−t1)ω1+1 for k = j
0 for k > j.
Situations exist for which inaccurate assessment of disease status is not the result of an
ambiguous diagnosis or the lack of medical expertise, but rather, due to a lower limit de-
tection of the diagnostic procedure. For instance, if the analytical lower limit is below the
detection of the assay, the outcomes may be misclassified. Although we develop method-
ology for the broad problem of estimating the true survival function from mismeasured
outcomes, we focus our data analysis and simulation studies for mismeasured outcomes
that originate from lower limit detection. Note that within the framework of lower limit
detection, and as discussed in Proposition 4.2.4, the NPV (γj) at time tj equals 1 for all
time points.
Before we proceed to inference and data analysis, we first discuss two analysis scenarios
(scenarios 1 and 2) that form the benchmark of our data analysis. In Section 4.2.3 we will
discuss scenario 1 which is then followed by a discourse of scenario 2 in Section 4.2.4.
4.2.3 Inference for Known ω1, ω2 and τ0
As mentioned in the preceding section, there are two scenarios (or options) for data analy-
sis, we now discuss details in regards to scenario 1. In this framework, we do not estimate
any parameters from the clinical study. The three parameters, ω1, ω2 and τ0 are acquired
from medical experts. The data analyst in collaboration with medical personnel may ob-
tain ω1, ω2 and τ0 from previous clinical studies or literature. These estimates are assumed
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to be known with confidence prior to the conduct of the clinical study, for an example,
Adeniji et al. (2014) as they assumed τ0 was known prior to the conduct of the study.
The measure at which the probability of misclassification changes over time is ω1, while
ω2 is the measure at which the probability of misclassification changes over time after the
occurrence of an observed event.
Since we assume that ω1, ω2 and τ0 are known and fixed prior to the start of the clinical
study, the variance-covariance formula for the variance of (4.7) is not very complex, this
is because the variability of ω1, ω2 and τ0 will be excluded from the variance-covariance
matrix of P0 in (4.7). The elements of P0 can be estimated by the product limit estimator
(Kalplan and Meier, 1958), which is also called the Kaplan-Meier (KM) estimator, as
follows
Sˆ(j) =
∏∑nj
i=1 I(Eij = 1)
nj
, j = 1, 2, . . . ,K,
where Eij is the event indicator for i-th subject at time tj , which is Eij = I(Ti = tj), and
nj is the number of survivors at tj−1, which is nj =
∑n(j−1)
m=1 I(Em(j−1) = 0). Let Pˆ0 =
(Sˆ(1), Sˆ(2), . . . , Sˆ(K))T . An expression for the estimator of the true survival distribution
is given by
Sˆ∗(j) = fj + gTj Pˆ0, j = 1, 2, . . . ,K. (4.8)
Breslow and Crowley (1974) showed that as n→∞, √n(Sˆ(j)− S(j)) converges in distri-
bution to a Gaussian process with expectation 0 and a variance-covariance function that
could be approximated using Greenwoods formula (Greenwood, 1926). By adapting their
techniques, we derive the asymptotic variance of the KM estimates and thus obtain the
asymptotic covariance matrix of our proposed estimator in the presence of right censoring
and mismeasured events. The estimated variance of the estimated true survival rate is
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given by
V̂ar(Sˆ∗(j)) = gTj V̂ar(Pˆ0)gj , (4.9)
where
V̂ar(Pˆ0) =

V̂ar(Sˆ(1)) Ĉov(Sˆ(1), Sˆ(2)) · · · Ĉov(Sˆ(1), Sˆ(K))
Ĉov(Sˆ(2), Sˆ(1)) V̂ar(Sˆ(2)) · · · Ĉov(Sˆ(2), Sˆ(K))
· · · · · · · · · · · ·
Ĉov(Sˆ(K), Sˆ(1)) Ĉov(Sˆ(K), Sˆ(2)) · · · V̂ar(Sˆ(K))

,
V̂ar(·) and Ĉov(·) are obtained from Greenwood (1926), and Breslow and Crowley (1974)
respectively, with V̂ar(Sˆ(j) = Sˆ2(j)
∏( ∑nj
i=1 I(Eij=1)
nj
[
nj−
∑nj
i=1 I(Eij=1)
]
)
, j = 1, 2, . . . ,K, and for
j < k; j, k = 1, . . . ,K, Ĉov(Sˆ(j), Sˆ(k)) = Sˆ(k)
Sˆ(j)
V̂ar(Sˆ(j)). Log-log transformed (1− α) CI
suggested by Borgan and Liestøl (1990) is given by
(
[Sˆ∗(j)]
1
θ , [Sˆ∗(j)]θ
)
,
where θ = exp
{
Zα/2σˆS∗(j)
log[Sˆ∗(j)]
}
and σˆ2S∗(j) =
V̂ ar{Sˆ∗(j)}
{Sˆ∗(j)}2 .
The next step is to prove consistency and asymptotic normality of our estimator of the
true survival distribution.
Theorem 4.2.6. (Consistency) Under Assumption 4.1 and model (4.3), the estimators
defined in (4.8) are consistent.
The result follows from the fact that the KM estimator Sˆ(j) of S(j) is consistent (Gill,
1983) and the estimator Sˆ∗(j) is a linear combination of Sˆ(j).
Theorem 4.2.7. (Asymptotic normality) Under Assumption 4.1 and model (4.3), the
estimators defined in (4.8) are asymptotically normal with mean S∗(j) and variance
Var(Sˆ∗(j)) = gTj Var(Pˆ0)gj , (4.10)
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where Var(Pˆ0) is a variance-covariance matrix, with Var(Sˆ(j)) along the diagonal and
Cov(Sˆ(j), Sˆ(k)), j < k; j, k = 1, . . . ,K, on the off-diagonal.
4.2.4 Inference for Unknown ω1, ω2 and τ0
There are situations for which ω1, ω2 and τ0 are not known with confidence, therefore
the aforementioned parameters will need to be estimated from data. This is the situation
that we present as scenario 2. In this framework, we estimate ω1, ω2 and τ0 directly
from the on-going clinical study. We first need to obtain the “pilot data” (complete data)
only on a small and randomly selected number of participants. Hence, the pilot data is
data on a small portion of the entire clinical study participants for which error-prone and
true outcomes are collected. This data is used to estimate ω1, ω2 and τ0. The remaining
(unselected) participants in the clinical study would only have the error-prone outcomes,
this set of observations we call the “analysis data”. Under this setting, the pilot data and
the analysis data are independent.
Sustained virologic response (SVR), defined as lack of detectable serum HCV RNA in
serum after 24 weeks of completing treatment was the primary endpoint in the VIRAHEP-
C study. There were two assays used to test viral load, the quantitative PCR-based assay
and the qualitative PCR-based assay, the latter was the assumed gold standard. Serum
samples were tested for HCV RNA levels using the quantitative PCR-based assay which
had a lower limit of sensitivity of 600 IU/ml, while the qualitative PCR-based had a
lower limit of sensitivity of 50 IU/ml. Viral negativity was assessed by the more sensitive
qualitative assay. If the qualitative assay (gold standard) was not available due to costs
or other reasons, it is reasonable to deduce that the outcomes from the less sensitive
(quantitative) assay are prone to error. Our research specifically addresses this issue, and
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we shall illustrate in Sections 4.3 and 4.4 that the true survival function can be accurately
obtained with a small pilot data and the error-prone assay.
We apply our methods to the study of the true time to viral negativity from the
VIRAHEP-C clinical trial. As discussed in Section 4.2.1, there are the true (latent) popu-
lation and the potentially misclassified (observed) population. In this view, the derivation
of the true survival function is intractable. Therefore, using the pilot dataset, we estimate
ω1, ω2 and τ0 in the proposed model (4.3) by minimizing the weighted sum of squared
distances between the estimated true survival rates (S∗P (k)) and the estimated approxi-
mated true survival rates (Sˆ∗(k)) based on (4.3). Under Assumption 4.1 the estimates,
(ωˆ1, ωˆ2, τˆ0), are obtained as follows
(ωˆ1, ωˆ2, τˆ0) = argmin
ω1,ω2,τ0
{ K∑
k=1
w(k)
(
S∗P (k)− Sˆ∗(k)
)2}
, (4.11)
where the weight w(k) is {Sˆ∗(k)}ρ1{1− Sˆ∗(k)}ρ2 for 0 ≤ ρ1, ρ2 ≤ 1 and k = 1, 2, . . . ,K.
Since fj and gj in (4.7) are the functions of P1, we rewrite them as fj(P1) and gj(P1)
accordingly. The true survival function in (4.7) can be rewritten as
S∗(j) = fj(P1) +
{
gj(P1)
}T
P0. (4.12)
Write P = (PT0 ,PT1 )T . Then, Pˆ0 can be the KM estimates using the analysis dataset and
Pˆ1 can be obtained by (4.11) using the pilot dataset. The extended expression for the
estimator of the true survival distribution is given by
Sˆ∗(j) = fj(Pˆ1) +
{
gj(Pˆ1)
}T
Pˆ0, j = 1, 2, . . . ,K. (4.13)
Since Pˆ1 and Pˆ0 are correspondingly obtained from the pilot dataset and analysis dataset,
they are independent.
Computing the standard error of Sˆ∗(j) in (4.13) is quite challenging since the delta
method may not be applicable due to the small size of the pilot data. Here, we develop a
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new approach to estimate the variance of Sˆ∗(j). Using the standard variance decomposi-
tion formula, we have
Var
[
Sˆ∗(j)
]
= E
[
Var(Sˆ∗(j)|Pˆ1)
]
+ Var
[
E
(
Sˆ∗(j)
∣∣Pˆ1)]. (4.14)
Since Var
[
Sˆ∗(j)|Pˆ1
]
and E
[
Sˆ∗(j)
∣∣Pˆ1] are functions of P0 and Pˆ1, we write σ2j (P0, Pˆ1) =
Var
[
Sˆ∗(j)|Pˆ1
]
and µj(P0, Pˆ1) = E
[
Sˆ∗(j)
∣∣Pˆ1]. Using (4.10), we have
σ2j (P0, Pˆ1) = {gj(Pˆ1)}TVar(Pˆ0){gj(Pˆ1)}. (4.15)
Since the size of the analysis dataset is relatively large and KM estimates, Pˆ0, are consis-
tent, µj(P0, Pˆ1) can be approximated by
µ˜j(P0, Pˆ1) = fj(Pˆ1) +
{
gj(Pˆ1)
}T
P0. (4.16)
To estimate E
[
σ2j (P0, Pˆ1)
]
and Var
[
µ˜j(P0, Pˆ1)
]
, we use the bootstrapping method. Let
{Pˆ(b)1 = (ωˆ(b)1 , ωˆ(b)2 , τˆ (b)0 ), b = 1, 2, . . . , B} denote a bootstrap sample of size B using the
pilot dataset. For given P0, we compute
Eˆ
[
σ2j (P0, Pˆ1)
]
=
1
B
B∑
b=1
{gj(P(b)1)}TVar(Pˆ0){gj(P(b)1 )} (4.17)
and
V̂ar(µ˜j(P0, Pˆ1)) =
1
B − 1
B∑
b=1
(µ˜j(P0, P
(b)
1 )− µ¯j(P0, Pˆ1))2, (4.18)
where µ¯j(P0, Pˆ1) = 1B
∑B
b=1 µ˜j(P0, P
(b)
1 ). Finally, letting P0 = Pˆ0 in (4.17) and (4.18), we
obtain an approximate standard error (se) of Sˆ∗(j) as follows:
se(Sˆ∗(j)) =
{
Eˆ
[
σ2j (Pˆ0, Pˆ1)
]
+ V̂ar(µ˜j(Pˆ0, Pˆ1))
}1/2
. (4.19)
Note that to compute Eˆ
[
σ2j (Pˆ0, Pˆ1)
]
in (4.19), we use {gj(P(b)1 )}T V̂ar(Pˆ0){gj(P(b)1 )} in
(4.17), where V̂ar(Pˆ0) is given by (4.9). We will examine the empirical performance of
se(Sˆ∗(j)) via simulation in Section 4.3.2.
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4.3 Stochastic Process Based Discrete Survival Times
The latent course of a foreign body (e.g. viral load, bacteria count) which underlies
disease progression may have a random probability distribution or pattern. In oncology,
tumor growth could be studied as a stochastic process. Even the spread of a fatal disease
within a closed community could be modeled through a random probability distribution.
The opportunities of real-life applications of time-to-event analysis derived from stochastic
processes are exciting. Thus, we examine the gamma process and Weiner process within
the discrete time-to-event setting.
4.3.1 Gamma Process
We infer that the course of the viral load follows a stochastic process that can be
modeled via a gamma process. If this conjecture is approximately correct, it will mean
that the closed-form expression of the true survival function can be derived analytically,
therefore simulation studies are unnecessary. This is a very favorable quality because the
survival estimates from the gold standard diagnostic tool can be directly calculated and
τ0 will depend on the diagnostic test. From the gamma process, we generate discrete
time survival data using a specified detection limit. For a gamma distribution denoted as
Gamma(a, b) (a, b > 0) with mean ab and variance ab2, suppose α(t) is an increasing and
right continuous function on [0,∞) with α(0) = 0. Furthermore, let W = {Wt, t ≥ 0}
be a stochastic process with the following properties: (i) W0 = 0, (ii) W has independent
increments in disjoint intervals, and (iii) for t > s, Wt −Ws ∼ Gamma(α(t) − α(s), b),
where b > 0 is a constant. Then W is called a Gamma process (GP), denoted by W ∼
GP(α(t), b). Let W ∗j = Wj−E[Wj ] and assume that we only observe Wj at integer times,
i.e., j = 1, 2, 3, . . . .
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Let W = {Wj , j ≥ 0} be a GP(j, 1), where Wj = X1 + · · ·+Xj and the Xj are i.i.d.
from Gamma(1, 1) for j = 1, . . . . The survival function at time tj = j with detection level
c is defined as Sc(j) = P (X1 ≥ 1 + c,X1 + X2 ≥ 2 + c, . . . ,X1 + · · · + Xj ≥ j + c). The
determinant of the Jacobian matrix is |J | = 1 and the joint distribution of W1, . . . ,Wj is
f(w1, . . . , wj) = exp(−wj), where w1 ≤ w2 ≤ · · · ≤ wj . We express the survival function
as
Sc(j) =
∫ ∞
c+j
∫ ∞
c+j−1
· · ·
∫ ∞
c+1
exp(−wj)1(w1 ≤ · · · ≤ wj−1 ≤ wj)dw1 · · · dwj−1dwj
=
∫ ∞
c+j
exp(−wj)
∫ wj
c+j−1
· · ·
∫ w2
c+1
dw1 · · · dwj =
∫ ∞
c+j
exp(−wj)Bj(c, wj)dwj , (4.20)
where Bj(c, wj) =
∫ wj
c+j−1 · · ·
∫ w2
c+1 dw1 · · · dwj−1 for j > 1 and B1(c, w1) = 1. From (4.20),
it is easy to show that
Bj(c, wj) =
∫ wj
c+j−1
Bj−1(c, wj−1)dwj−1 (4.21)
for j = 2, . . . . The following lemma provides the closed-form expression of Bj(c, wj).
Lemma 4.3.1. For Bj(c, wj) in (4.21), we have
Bj(c, wj) =
(wj − c)j−1
(j − 1)! −
(wj − c)j−2
(j − 2)!
for j = 2, . . . .
Using Lemma 4.3.1, we obtain the closed-form expression of the survival function,
which is given in the next theorem.
Theorem 4.3.2. Suppose W = {Wj , j = 1, 2, . . . } follows GP(j, 1). The survival function
at time tj with a lower detection limit level c is given by
Sc(j) = P (X1 ≥ 1 + c,X1 +X2 ≥ 2 + c, . . . ,X1 + · · ·+Xj ≥ j + c)
=
∫ ∞
c+j
exp (−wj)Bj(c, wj)dwj = j
(j−1)
(j − 1)! exp {−(c+ j)}.
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Table 4.1: Results of the approximation of survival probabilities for time to viral negativity
at selected time points for c∗ = −0.8 and c = −0.4.
Time True Observed Approximated
(c∗ = −0.8) (c = −0.4) (ρ1 = 0.5, ρ2 = 0.5) (ρ1 = 1, ρ2 = 0)
t1 0.819 0.549 0.764 0.784
t2 0.602 0.404 0.627 0.637
t3 0.499 0.334 0.530 0.527
t4 0.435 0.291 0.455 0.444
t5 0.391 0.262 0.395 0.380
t6 0.357 0.240 0.348 0.330
t7 0.332 0.222 0.309 0.292
t8 0.311 0.208 0.278 0.263
Under the lower-limit detection framework, if c∗ ≤ c then P (T ∗ ≥ T ) = 1, where ∗
denotes the truth (or gold standard), we examine our proposed model under this frame-
work. We consider two detection limits for the true and observed events as c∗ = −0.8,
and c = −0.4. In this case, the true survival function is Sc∗(j) = j(j−1)(j−1)! exp {−(c∗ + j)}
and the observed survival function is Sc(j) =
j(j−1)
(j−1)! exp {−(c+ j)}. Let S∗c (j) be the ap-
proximate true survival function based on (4.7), where P0 is computed using Sc(j). It
does not appear that there exist (ω1, ω2, τ0) such that S
∗
c (j) is exactly equal to Sc∗(j).
Therefore, we use (4.11) with S∗P (j) and Sˆ
∗(j) replaced by Sc∗(j) and S∗c (j), respectively,
to find the optimal values of (ω1, ω2, τ0). Table 4.1 shows results for ρ1 = 0.5 and ρ2 = 0.5
and ρ1 = 1 and ρ2 = 0. The optimal values of (ω1, ω2, τ0) are (0.326, 0.000, 0.524) and
(0.000, 0.607, 0.480) for ρ1 = 0.5 and ρ2 = 0.5 and ρ1 = 1 and ρ2 = 0 correspondingly.
Those approximated true survival functions in Table 4.1 are illustrated in Figure 4.1. The
difference between the naive (observed) and true survival rates at each time point reflects
the mismeasured outcomes.
At time t1, the approximated true survival rates for ρ1 = 0.5 and ρ2 = 0.5 and
ρ1 = 1 and ρ2 = 0 are 0.764 and 0.784, respectively, while at time t8 the corresponding
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Figure 4.1: True, observed, and approximated true survival functions with the lower
detection limit levels as c∗ = −0.8 and c = −0.4 for ρ1 = 0.5 and ρ2 = 0.5 (a) and ρ1 = 1
and ρ2 = 0 (b).
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approximate survival rates are 0.278 and 0.263. The approximated true survival rate of
0.784 for ρ1 = 1 and ρ2 = 0 at time t1 is closer to the estimated true survival rate of
0.819 for ρ2 = 0.5 and ρ1 = 1. This result is in contrast to the survival rates at time t8,
where the approximated true survival rate of 0.278 for ρ1 = 0.5 and ρ2 = 0.5 is closer
to the true survival rate of 0.311 for ρ1 = 1 and ρ2 = 0. From Figure 4.1, we observe
that the approximated true survival function is much closer to the true survival function.
This indicates that the model in Theorem 4.2.5 works well under gamma process. The
naive (observed) survival function does not perform well in estimating the true survival
function.
We extend Theorem 4.3.2 with Xj ∼ Gamma(1, λ). Since Xjλ ∼ Gamma(1, 1), we have
S(c,λ)(j) = P (X1 ≥ λ+ c,X1 +X2 ≥ 2λ+ c, . . . ,X1 + · · ·+Xj ≥ nλ+ c)
= P (
X1
λ
≥ 1 + c
λ
,
X1 +X2
λ
≥ 2 + c
λ
, . . . ,
X1 + · · ·+Xj
λ
≥ n+ c
λ
)
=
∫ ∞
c
λ
+j
exp (−yj)Bj
( c
λ
, yj
)
dyj = S c
λ
(j), (4.22)
where Yj =
X1+···+Xj
λ . Using (4.22), the formula of S(c,λ)(j) with Xj ∼ Gamma(1, λ) is
given in Corollary 4.3.3.
Corollary 4.3.3. Suppose that the Xj are i.i.d. from Gamma(1, λ) for j = 1, . . . . Then,
the survival function at time tj with a lower detection limit level as c is given by
S(c,λ)(j) = P (X1 ≥ λ+ c,X1 +X2 ≥ 2λ+ c, . . . ,X1 + · · ·+Xj ≥ nλ+ c) = S cλ (j).
4.3.2 Weiner process
We now model the viral load course via a standard Brownian motion process (Weiner
process). Unlike the gamma process, this approach does not have the favorable quality of
a closed-form formulation of the true survival function, as a result, we assess the properties
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Table 4.2: The Estimates under the Brownian motions process with c∗ = −0.5 and c = 0.2
for (ρ1 = 0.5, ρ2 = 0.5) and (ρ1 = 1, ρ2 = 0).
n0 = 30
(ρ1 = 0.5, ρ2 = 0.5) (ρ1 = 1, ρ2 = 0)
Time True Observed Approximated ASE MCSE CP Approximated ASE SSD CP
t1 0.691 0.420 0.671 0.067 0.064 0.908 0.677 0.067 0.065 0.918
t2 0.549 0.309 0.558 0.066 0.064 0.960 0.559 0.068 0.065 0.958
t3 0.468 0.255 0.482 0.067 0.065 0.940 0.479 0.069 0.067 0.944
t4 0.415 0.223 0.424 0.067 0.067 0.934 0.419 0.069 0.070 0.924
t5 0.377 0.199 0.377 0.067 0.069 0.918 0.371 0.069 0.071 0.904
t6 0.347 0.183 0.339 0.066 0.069 0.902 0.333 0.068 0.071 0.880
t7 0.324 0.170 0.308 0.065 0.068 0.872 0.301 0.066 0.070 0.844
n0 = 60
(ρ1 = 0.5, ρ2 = 0.5) (ρ1 = 1, ρ2 = 0)
Time True Observed Approximated ASE MCSE CP Approximated ASE SSD CP
t1 0.691 0.421 0.664 0.048 0.048 0.846 0.670 0.049 0.049 0.892
t2 0.550 0.309 0.557 0.048 0.047 0.946 0.559 0.048 0.048 0.944
t3 0.469 0.256 0.484 0.048 0.047 0.940 0.483 0.049 0.048 0.946
t4 0.416 0.223 0.427 0.049 0.048 0.944 0.424 0.051 0.050 0.938
t5 0.377 0.200 0.381 0.050 0.050 0.938 0.376 0.051 0.052 0.930
t6 0.348 0.184 0.343 0.050 0.051 0.924 0.338 0.051 0.053 0.906
t7 0.324 0.171 0.311 0.050 0.052 0.910 0.305 0.051 0.053 0.882
n0 = 90
(ρ1 = 0.5, ρ2 = 0.5) (ρ1 = 1, ρ2 = 0)
Time True Observed Approximated ASE MCSE CP Approximated ASE SSD CP
t1 0.692 0.421 0.662 0.041 0.040 0.832 0.669 0.042 0.041 0.858
t2 0.551 0.309 0.556 0.041 0.039 0.930 0.560 0.041 0.039 0.932
t3 0.470 0.256 0.484 0.041 0.038 0.936 0.484 0.042 0.039 0.934
t4 0.416 0.223 0.428 0.042 0.038 0.944 0.426 0.043 0.039 0.946
t5 0.378 0.200 0.382 0.043 0.039 0.948 0.377 0.044 0.041 0.946
t6 0.348 0.184 0.344 0.043 0.040 0.946 0.338 0.045 0.042 0.946
t7 0.325 0.171 0.311 0.043 0.041 0.932 0.305 0.045 0.042 0.920
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of our estimator through simulation studies. The Brownian motion process on the interval
[0,K] is a random variable, W (t), which depends continuously on k ∈ [0,K] and satisfies
the following: W (0) = 0, W (k)−W (s) ∼ √k − s ∗N(0, 1), for 0 ≤ s < k ≤ K and where
K = 8 is the maximum predetermined number of clinical visits.
To simulate, we discretize the BM with a timestep, dt, as the ratio of the maximum
time interval over the number of BM steps, so we have K/J = 0.001, where J = 8, 000.
We conduct the simulation study as follows. For each simulated dataset of size n, we
generate Bi = (Bij)
′ as Bij ∼ N(0, 11000) and obtain Wij =
∑j
t=1Bit, for i = 1, . . . , n and
j = 1, . . . , J . By setting Wi0 = 0, J = 8000, we have Wij−Wi0 ∼ N(0, j1000). We consider
only K time points of Witk , defined as tk = 1000k for k = 1, 2, . . . ,K.
Figure 4.2: The means of true and observed, and approximated true survival rates using
n0 = 30 and n = 300 under Brownian motion with c
∗ = −0.5 and c = 0.2 for ρ1 = 0.5 and
ρ2 = 0.5 (a) and ρ1 = 1 and ρ2 = 0 (b).
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Since we are comparing the error-prone diagnostic test to the gold standard, we there-
fore specify two detection levels, c = 0.2(c∗ = −0.5) for observed (true) survival time.
The observed (Ti) and true (T
∗
i ) survival times are generated as Ti = min{k : Witk ≤ 0.2}
and T ∗i = min{k : Witk ≤ −0.5}. We then generate 1000 datasets with n = 300. For the
`− th analysis dataset, a pilot dataset is randomly sampled with n0 subjects for n0 = 30,
n0 = 60, and n0 = 90, which correspond to the 10%, 20%, and 30% of n. Using the pilot
data, we obtain parameter estimates, Pˆ`1 = (ωˆ`1, ωˆ`2, τˆ`0) and B = 200 sets of bootstrap-
ping estimates, Pˆ(b)`1 = (ωˆ
(b)
`1 , ωˆ
(b)
`2 , τˆ
(b)
`0 ), for b = 1, . . . , B. For the ` − th analysis dataset
with n − n0 subjects, the approximated true survival function and estimated variance of
the approximated true survival function are obtained using Pˆ`1 and Pˆ
(b)
`1 for b = 1, . . . , B.
Figure 4.3: The means of true, observed, and approximated true survival rates using
n0 = 60 and n = 300 under Brownian motion with c
∗ = −0.5 and c = 0.2 for ρ1 = 0.5 and
ρ2 = 0.5 (a) and ρ1 = 1 and ρ2 = 0 (b).
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Table 4.2 shows results. Figure 4.2-4.3 show the means of true, observed, and approx-
imated true survival functions from the analysis datasets using the estimated parameters
from pilot datasets with n0 = 30 and n0 = 60, respectively. The approximated true
survival function almost overlaps the true survival function except at t1 and t7.
These results suggest that (i) for each time point, the difference between the approxi-
mated true survival rates are less than 0.005 for n0 = 30, n0 = 60, and n0 = 90 except at
time point t1; (ii) the difference between true and approximated true survival rates are less
than 0.015 from time t2 to t6; (iii) estimated variance of estimated true survival function
using formula in (4.19) works well since the difference between ASE and SSD are less than
0.005; (iv) at early and late time points, for example t1 and t7, the corresponding CP are
low but this is due to the bias of the approximated true survival rates.
Most importantly, the results of our simulation study validate the mathematical results
from section 4.2.4. When the course of the viral load does not follow a gamma process,
we have shown that the parameters, ω1, ω2 and τ0 can be estimated through a small pilot
study. This is useful development for clinical trial studies for which the parameters are
unknown and the latent stochastic process of disease can not be confirmed.
4.4 Analysis of VIRAHEP-C Data
VIRAHEP-C study was an international clinical trial, sponsored by the NIDDK-NIH,
and designed to test the hypothesis that African Americans respond less well to antiviral
therapy than Caucasian Americans. A total of 401 chronically infected participants with
Hepatitis-C virus (HCV) of genotype 1 were enrolled. Of these, we select those that had
evaluations from the quantitative and qualitative assays at every visit, hence the reduced
sample size of 372. We study up to the 24 week timepoint, as this was the primary
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endpoint in the VIRAHEP-C study, the times are as follows: Days t1 = 1, t2 = 2, t3 = 7,
and weeks t4 = 2, t5 = 4, t6 = 8, t7 = 12, and t8 = 24. True event and error-
prone events at time tk are defined as E
∗(j) = I{viral levels ≤ 50IU/ml at tj} and
E(j) = I{viral levels ≤ 600IU/ml at tj}.
Table 4.3: Data analysis results for (ρ1 = 0.5, ρ2 = 0.5) and (ρ1 = 1, ρ2 = 0) using n0 = 37
and n0 = 74 to obtain the parameters (ω1, ω2, τ0).
n0 = 37
(ρ1 = 0.5, ρ2 = 0.5) (ρ1 = 1, ρ2 = 0)
Time True Observed Approximated SE LCI UCI Approximated SE LCI UCI
t1 0.994 0.982 0.990 0.005 0.975 0.996 0.998 0.004 0.939 1
t2 0.991 0.973 0.985 0.008 0.959 0.995 0.981 0.008 0.958 0.992
t3 0.973 0.949 0.972 0.012 0.935 0.988 0.970 0.010 0.942 0.985
t4 0.949 0.887 0.937 0.022 0.877 0.968 0.941 0.016 0.901 0.966
t5 0.850 0.722 0.843 0.041 0.742 0.907 0.866 0.028 0.801 0.911
t6 0.675 0.481 0.688 0.052 0.572 0.778 0.692 0.038 0.610 0.760
t7 0.444 0.327 0.563 0.072 0.412 0.689 0.461 0.067 0.327 0.585
t8 0.286 0.268 0.415 0.073 0.272 0.551 0.320 0.071 0.189 0.459
n0 = 74
(ρ1 = 0.5, ρ2 = 0.5) (ρ1 = 1, ρ2 = 0)
Time True Observed Approximated SE LCI UCI Approximated SE LCI UCI
t1 0.993 0.983 0.997 0.003 0.982 0.999 0.998 0.002 0.979 1
t2 0.993 0.973 0.994 0.007 0.949 0.999 0.982 0.008 0.958 0.993
t3 0.973 0.946 0.983 0.010 0.949 0.994 0.970 0.010 0.942 0.984
t4 0.946 0.886 0.957 0.016 0.913 0.979 0.939 0.015 0.902 0.962
t5 0.849 0.715 0.880 0.026 0.818 0.922 0.864 0.022 0.814 0.902
t6 0.664 0.480 0.694 0.039 0.611 0.763 0.685 0.031 0.621 0.741
t7 0.438 0.321 0.483 0.058 0.367 0.590 0.460 0.040 0.379 0.537
t8 0.288 0.266 0.311 0.060 0.199 0.428 0.314 0.030 0.256 0.374
n0 = 111
(ρ1 = 0.5, ρ2 = 0.5) (ρ1 = 1, ρ2 = 0)
Time True Observed Approximated SE LCI UCI Approximated SE LCI UCI
t1 0.992 0.981 0.996 0.003 0.983 0.999 0.996 0.003 0.984 0.999
t2 0.992 0.973 0.991 0.007 0.962 0.998 0.991 0.008 0.951 0.998
t3 0.969 0.942 0.971 0.01 0.943 0.985 0.971 0.01 0.943 0.985
t4 0.942 0.877 0.933 0.017 0.892 0.959 0.933 0.016 0.894 0.957
t5 0.838 0.704 0.844 0.024 0.791 0.885 0.843 0.022 0.794 0.882
t6 0.662 0.481 0.661 0.031 0.596 0.717 0.66 0.03 0.598 0.714
t7 0.453 0.333 0.452 0.04 0.372 0.529 0.452 0.037 0.378 0.522
t8 0.295 0.270 0.321 0.032 0.26 0.384 0.321 0.031 0.261 0.382
As explained in section 4.2.4, in situations for which ω1, ω2 and τ0 are unknown, we
first need to establish a pilot data and consequently, the analysis data. We make the pilot
data to be a random sample of 10% (n0 = 37) of the VIRAHEP-C data (n = 372). In
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addition, we consider a second scenario for which the pilot data is twice or tree times as
large (10%). Using true and observed survival functions from the pilot data, we obtain
estimates, Pˆ1 and Pˆ
(b)
1 for b = 1, . . . , 200 defined on section 4.2.4. These estimates optimize
the distance metric,
8∑
k=1
w(k){S∗P (k)− Sˆ∗(k)}2, (4.23)
where the weight w(k) is {Sˆ∗(k)}ρ1{1 − Sˆ∗(k)}ρ2 . Using the estimates, we obtain the
approximated true survival function as well as the 95% confidence interval (CI) of the
analysis data, we present results in Table 4.3.
Figure 4.4: The survival functions of analysis data set for ρ1 = 0.5 and ρ2 = 0.5 with
n0 = 37 (a) and n0 = 74 (b).
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The distance between observed and true survival rates at each time points is caused
by the mismeasured outcomes. The estimates of (ω1, ω2, τ0) for ρ1 = 0.5 and ρ2 = 0.5
are correspondingly (0.000, 0.010, 0.5405) and (0.000, 0.278, 0.205) with n0 = 37 and n074.
70
The estimates for ρ1 = 1, and ρ2 = 0 are (0.000, 31.943, 0.126) and (0.000, 32.294, 0.126)
with n0 = 37 and n0 = 74, respectively.
Figure 4.5: True and observed survival functions, and approximated true survival function
for ρ1 = 1 and ρ2 = 0 with n0 = 37 (a) and n0 = 74 (b).
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Using a pilot data with n0 = 37, our proposed method performs very well. Of note,
the bias between our proposed method of approximating the true survival and the true
survival increases in the later time points t8 for ρ1 = 0.5 and ρ2 = 0.5, this is because
the differences at late time points give less weight for ρ1 = 0.5 and ρ2 = 0.5 compared to
those for ρ1 = 1 and ρ2 = 0 for weight w(k) in (4.23). The conclusion from the pilot data
with n0 = 74 is similar.
Figure 4.4 shows the survival functions with ρ1 = 0.5, and ρ2 = 0.5 for weight w(k),
which are true (blue solid line), observed (red solid line), and approximated (green dashed
line) true survival functions of analysis dataset. The survival functions for ρ1 = 1 and
ρ2 = 0 in (4.23) are shown in Figure 4.5.
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Figure 4.6: True and approximated true survival functions of analysis dataset, and 95 %
CI’s using n0 = 37 ((a) and (b)) and n0 = 74 ((c) and (d)).
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(a) ρ1 = 0.5 and ρ2 = 0.5 (b) ρ1 = 1 and ρ2 = 0
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(c) ρ1 = 0.5 and ρ2 = 0.5 (d) ρ1 = 1 and ρ2 = 0
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The true survival function, approximated true survival function, and 95% confidence
bands CI for each time point are displayed in Figure 4.6. From the analysis of one group
data, we observe that (i) from time t1 to t6, the differences between the true and approx-
imated true survival rates are less than 0.03; (ii) from time t7 to t8, the bias is relatively
large for ρ1 = 0.5 and ρ2 = 0.5 with n0 = 37; and (iii) for ρ1 = 1 and ρ2 = 0, the dif-
ferences of the true and approximated true survival rates are less than 0.03 with n0 = 37
and n0 = 74.
Figure 4.7: True and approximated true survival functions of analysis dataset with two
groups African male and Caucasian male for ρ1 = 0.5 and ρ2 = 0.5 (a) and ρ1 = 1 and
ρ2 = 0 (b).
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Now, we focus on comparing differences of survival rates between two groups, African
American males and Caucasian males. We use the the data based on the error-prone
(quantitative) assay. The size of African American male and Caucasian male groups are
115 and 130, respectively. We select pilot data with n0 = 35 from the African American
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data and with n0 = 39 from Caucasian data. The solid and dashed lines in Figure 4.7
correspond to the observed and approximated true survival functions of the analysis data
for African American male (AF M) and Caucasian male (CA M). We see that the survival
functions between error-prone assay and the gold standard are different. For example, at
time t6, we observe that the difference between the two groups for the observed data is
much smaller than difference between approximated true survival rates. The results of
data analysis with one group show that the approximated true survival function is very
close to the true survival function up to time t6. At t6, the difference of the observed and
approximated true survival rates are correspondingly 0.138 and 0.234 for ρ1 = 0.5, and
ρ2 = 0.5; and the difference of approximated true survival rate is 0.235 forρ1 = 1, and
ρ2 = 0, respectively. The p-value of the Wald statistic for the difference of the observed
survival rates is 0.068, which implies the difference is not significant. However, the p-value
of the Wald statistic for the difference of the approximated true survival rates is 0.014 for
ρ1 = 0.5, and ρ2 = 0.5 and 0.006 for ρ1 = 1, and ρ2 = 0, which indicates the difference of
survival rates between two groups is significant.
Chapter 5
Concluding Remarks and Extension
5.1 Concluding Remarks of Models for Discrete Survival Data
As it is well known, the constant hazard model is the only model, which possesses
the memoryless property for the continuous survival time. For the discrete survival time,
under certain mild conditions, we can show that the ELTH model is memoryless if and
only if αk is constant, which implies that the baseline hazard function h0(k) is constant.
To compute the cure rate, we use the convergent criterion
kr = min
{
k :
∣∣∣S(k + 1|x,β)− S(k|x,β)
S(k|x,β)
∣∣∣ < 10−13}
and then approximate S(∞|x,β) by S(kr|x,β). The cure rate is useful in classifying breast
cancer patients into different risk groups and aiding physicians to better treat patients.
In Section 2.3.12, we introduced the AIC and BIC criteria to determine the choice of
links as well as the baseline hazards under the ELTH model. According to the simulation
study in Section 3.1, AIC outperformed BIC. For the SEER breast cancer data, both AIC
and BIC selected the same best model under logit, C-log-log, and t4 links except for the
probit link. Thus, AIC is a more desirable criterion in order to select a better fit model
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since BIC may over-penalize the dimension and sample size. Also, in Section 3.2, we
carried out a detailed analysis of the subset of the SEER breast cancer data. Our study
cohort consisted of the female subjects who were at least 20 years old at diagnosis and were
diagnosed with regional extension, grade III or IV, and stage III breast cancer between
1990 and 2003. As pointed out by an anonymous reviewer, there were missing observations
among PN, ER, PR, race, Rad, and Surg. The missing percentages for PN, race, Rad,
and Surg were small, ranging from 0.25% to 3.28%, while the missing percentages for ER
and PR were 9.98% and 10.41%. We simply excluded those subjects with missing values
in any of these covariates and carried out a complete case analysis based on the 2096
subjects. However, our proposed methodology can be extended to allow the inclusion of
subjects who had missing values in PN, ER, PR, race, Rad, and Surg. Following Ibrahim
et al. (2012), such an extension requires the EM algorithm to carry out the data analysis,
which can well be considered as a future research topic.
In Section 4.2.4, instead of applying delta method to obtain the se of Sˆ∗(j), we de-
velop the new approach using the standard variance decomposition approach and provide
formula in (4.19). Also, Table 4.2 in Section 4.3 shows the great empirical performance of
the approach since the the differences between ASE’s and SSD’s are less than 0.005.
Now, we exam the approximate se of Sˆ∗(j) using delta method under the same simu-
lation setting in Section 4.3.2. We derive the formula for the approximate se using delta
method. Using delta method, and the independence of the pilot dataset and analysis
dataset, the estimated the variance of the estimated true survival rate is given as follows
V̂ar
(
Sˆ∗(j)
)
= mTj V̂ar
(
Pˆ
)
mj , (5.1)
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where
mj =
( S∗(j)
∂S(1)
, · · · , S
∗(j)
∂S(K)
,
S∗(j)
∂τ0
,
S∗(j)
∂ω1
,
S∗(j)
∂ω2
)T ∣∣∣
S∗(j)=Sˆ∗(j)
=
(
gj(·), fj(·)
∂τ0
+
{gj(·)
∂τ0
}T
P0,
fj(·)
∂ω1
+
{gj(·)
∂ω1
}T
P0,
fj(·)
∂ω2
+
{gj(·)
∂ω2
}T
P0
)T ∣∣∣
P0=Pˆ0,P1=Pˆ1
(5.2)
and  V̂ar(Pˆ0) Ĉov(Pˆ0, Pˆ1)
Ĉov(Pˆ1, Pˆ0) V̂ar(Pˆ1)
 =
V̂ar(Pˆ0) 0
0 V̂ar(Pˆ1)
 . (5.3)
Table 5.1: The Estimates under the Brownian motions process using delta method for
approximated SE.
n0 = 30
(ρ1 = 0.5, ρ2 = 0.5) (ρ1 = 1, ρ2 = 0)
Time True Observed Approximated ASE SSD CP Approximated ASE SSD CP
t1 0.691 0.420 0.671 0.067 0.064 0.908 0.677 0.067 0.065 0.918
t2 0.549 0.309 0.558 6.539 0.064 0.990 0.559 0.186 0.065 0.992
t3 0.468 0.255 0.482 11.063 0.065 0.996 0.479 0.302 0.067 0.998
t4 0.415 0.223 0.424 13.832 0.067 0.996 0.419 0.384 0.070 0.996
t5 0.377 0.199 0.377 15.220 0.069 0.996 0.371 0.437 0.071 0.992
t6 0.347 0.183 0.339 15.660 0.069 0.990 0.333 0.468 0.071 0.982
t7 0.324 0.170 0.308 15.701 0.068 0.988 0.301 0.486 0.070 0.976
n0 = 60
(ρ1 = 0.5, ρ2 = 0.5) (ρ1 = 1, ρ2 = 0)
Time True Observed Approximated ASE SSD CP Approximated ASE SSD CP
t1 0.691 0.421 0.664 0.048 0.048 0.846 0.670 0.049 0.049 0.892
t2 0.550 0.309 0.557 0.095 0.047 0.950 0.559 0.054 0.048 0.946
t3 0.469 0.256 0.484 0.138 0.047 0.962 0.483 0.069 0.048 0.962
t4 0.416 0.223 0.427 0.168 0.048 0.976 0.424 0.082 0.050 0.978
t5 0.377 0.200 0.381 0.186 0.050 0.984 0.376 0.090 0.052 0.988
t6 0.348 0.184 0.343 0.190 0.051 0.986 0.338 0.095 0.053 0.990
t7 0.324 0.171 0.311 0.189 0.052 0.984 0.305 0.098 0.053 0.980
n0 = 90
(ρ1 = 0.5, ρ2 = 0.5) (ρ1 = 1, ρ2 = 0)
Time True Observed Approximated ASE SSD CP Approximated ASE SSD CP
t1 0.692 0.421 0.662 0.041 0.040 0.830 0.669 0.042 0.041 0.858
t2 0.551 0.309 0.556 0.041 0.039 0.932 0.56 0.042 0.039 0.932
t3 0.470 0.256 0.484 0.044 0.038 0.950 0.484 0.048 0.039 0.956
t4 0.416 0.223 0.428 0.049 0.038 0.968 0.426 0.055 0.039 0.970
t5 0.378 0.200 0.382 0.054 0.039 0.976 0.377 0.061 0.041 0.978
t6 0.348 0.184 0.344 0.056 0.040 0.986 0.338 0.064 0.042 0.990
t7 0.325 0.171 0.311 0.058 0.041 0.978 0.305 0.065 0.042 0.976
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Table 5.1 shows the ASE’s, SSD’s and CP’s using the delta methods. From the Table
5.1, we observe that (i) ASEs are too large compared to SSDs at every time points,
especially for n0 = 30 and (ρ1 = 0.5, ρ2 = 0.5) for w(k) in (4.11);(ii) from t3 to t7, all
of CP’s are above 0.99 for n0 = 30; and (iii) as the size of pilot dataset is increasing
to n0 = 90, the ASEs are getting close to SSDs but still over estimate the se of Sˆ
∗(j).
Especially, ASEs for (ρ1 = 0.5, ρ2 = 0.5) from t2 to t7 are over 1, which is impossible. As
we discussed in Section implement, this confirms the size of pilot data with n0 = 30, 60
or 90 is too small to obtain proper estimate of the standard error of Sˆ∗(j) using delta
method.
5.2 Extension of Models for Discrete Survival Data
In Section 3.2, the knots, sj ’s, were specified by the Bi-Sectional Quantile Partition
(BSQP) method proposed by Zhang et al. (2013), and the number (J) of intervals was
determined by the AIC or BIC criterion. This approach can be extended by modeling
sj and J simultaneously via the dynamic models of Kim et al. (2007) and Wang et al.
(2013). Such an extension improves flexibility of the model but also dramatically increases
computation complexity.
In Section 2.3.8, we propose models for the baseline survival function with piecewise
segment of the first J−1 intervals and linear function for the αk, which is decreasing in k.
This approach can be extended by adapting integrated-spline in Lin et al. (2015), which
is monotone increasing on [m0,mJ − 1) such as
αk =
J+d−1∑
`=1
φ`B`(tk|d) + φJ(tk −mJ−1)+, (5.4)
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for φ` < 0, ` = 1, 2, . . . , J where B`(·|d) is the integrated-spline basis functions with degree
d ≥ 2 and the integrated-spline, B, is the integrated functions of monotone spline described
in Ramsay (1988). Due to the assumption of strictly decreasing αk in k, the degree of the
baseline is d ≥ 2 and the restriction for the coefficients is φ` < 0, ` = 1, 2, . . . , J .
5.3 Extension of Discrete Time Survival Data with Mismeasured Outcomes
As we observe from the extended study based on the stochastic process and an analysis
of the real data, the proposed method works well in approximating the true survival
function. However, the limitation is to obtain the parameters defined in (4.3) and (4.4)
from a fraction of the on-going study. Following Huang et al. (2009), we directly model
the course of viral load using latent variable and stochastic process as follows
Y (t) =

0 if Z(t) > c,
1 if Z(t) ≤ c,
where t ≥ 0 and Z(t) is a viral level with
Z(t) = x′β1 + h(t,β2) + (0)I[t = 0] +
1
g(t)
(t)I[t > 0];
g(t) is a known nonnegative continuous function; and {} = {(t), t ≥ 0} is a known
stochastic process with (0) ≡ 0. The attractive feature of this are to capture the viral
load between the predetermined discrete time points and the dependency of Y (t) over time
t. For the mismeasured discrete survival data, we will also extend the proposed method
by developing Bayesian methods via the logistic regression model for the true hazard at
each time points tj as
h∗(j|x) = exp(αj + x
′β)
1 + exp(αj + x′β)
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for j = 1, 2, . . . , where β is a vector of the regression coefficients. We assume a piecewise
constant model for αj as follows
αj = ψ0 +
p∑
i=1
ψiI(si ≤ tj < si+1),
where 0 < s1 < · · · < sp < sp+1 = ∞, and the indicator function I(si ≤ tj < si+1) = 1 if
si ≤ tj < si+1 and 0 otherwise. Let θj(x) and φj(x) be sensitivity and specificity at time
tj and define as follows
θj(x) = P (T > tj |T ∗ > tj ,x)
and
φj(x) = P (T ≤ tj |T ∗ ≤ tj ,x).
Also, we obtain the exact relationship between the true and observed survival function
using the sensitivity and specificity as follows.
Lemma 5.3.1. The exact relationship between observed and true survival functions is
given by
S(j|x,β) = {1− φj(x)}{1− S∗(j|x,β)}+ θj(x)S∗(j|x,β).
The observed data likelihood function can be written as follows
L(β, h0|D) =
n∏
i=1
{S(j − 1|x,β)− S(j|x,β)}δi{S(j|x,β)}1−δi
=
n∏
i=1
{S(j − 1|x,β)
S(j|x,β) − 1
}δi{S(j|x,β)}. (5.5)
We will derive the observed data hazard h(j|x) as a function of the parameter in the true
hazard using the exact relationship of observed and true outcomes with sensitivity and
80
specificity. Likelihood in (5.5) can be rewritten given by
L(β, h0|D) =
n∏
i=1
[
{1− φj−1(x)}{1− S∗(j − 1|x,β)}+ θj−1(x)S∗(j − 1|x,β)
{1− φj(x)}{1− S∗(j|x,β)}+ θj(x)S∗(j|x,β) − 1
]δi
× [{1− φj(x)}{1− S∗(j|x,β)}+ θj(x)S∗(j|x,β)].
After all, we will estimate the αj and β in the true hazard by fitting data.
5.4 Extension of the New Method for Discrete Time Survival Data with
Mismeasured Outcomes under T ∗ ≤ T
We focus on the low limit detection problem in Section 4.3 and 4.4 under assumption
T ∗ ≥ T in Assumption 4.1. If the low detection limit of gold standard test is lower
than that of error prone test under the low limit detection problem, then P (T ∗ ≥ T )
in Assumption 4.1 is reasonable. However, it is vice versa under different situation. For
example, Balasubramanian and Lagakos (2001) developed a new method to estimate the
risk of perinatal transmission of HIV-1 during the late stages of pregnancy. Since all of the
test can occur after birth, the true survival time is always less or equal to the error prone
observed survival time. We discuss about the model in (4.4) under this new condition and
show simulation results.
Assumption 5.1: The observed event does not happen before the true event. That is,
P (T ∗ ≤ T ) = 1.
Under the Assumption 5.1, we have the following Proposition instead of the Proposition
4.2.4 under Assumption 4.1.
Proposition 5.4.1. Under Assumption 5.1, we obtain that (i) the PPV at time tj is
τj = 1 for all j = 1, 2 . . . ;
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and (ii) the NPV at time tj is
γj =
P (E∗j = 0)
P (Ej = 0)
=
S∗(j)
S(j)
.
The attractive feature of the γj in Proposition 5.4.1 is that the γj is simply a ratio of the
true survival function to the observed survival function. Under a separate assumption to
that used in Theorem 4.2.5, we formulate another way to obtain the true survival function
according to conditions given under Assumption 5.1 by plugging τj = 1 and formula of γj
in (ii) of Proposition 4.2.3 into Lemma 4.2.1.
Theorem 5.4.2. Under Assumptions 5.1, the true survival function is proportional to
the observed survival function at time tj as follows
S∗(j) =
[
1− 1
jϕ1
j∑
k=1
{1− γ0}(tj−tk)ϕ2+1
]
S(j),
where ϕ1 ≥ 1 and ϕ2 ≥ 0.
We exam the model in (4.4) under Gamma process. The new approximated true sur-
vival function in Theorem 5.4.2 depends on three parameters (ϕ1, ϕ2, γ0). Using the pilot
dataset, ϕ1, ϕ2, and γ0 are estimated by minimizing weighted sum of squared distance
between S∗P (k) and Sˆ
∗(k) as follows
(ϕˆ1, ϕˆ2, γˆ0) = argmin
(ϕ1,ϕ2,γ0)
{ K∑
k=1
w(k)
(
S∗P (k)− Sˆ∗(k)
)2}
, (5.6)
where the weight w(k) is {Sˆ∗(k)}ρ1{1− Sˆ∗(k)}ρ2 for 0 ≤ ρ1, ρ2 ≤ 1 and k = 1, 2, . . . ,K.
Using the formula in Theorem 4.3.2, the true and observed survival functions are obtained
with two detection limits as c∗ = −0.6 and c = −0.4, respectively. Similar to the procedure
in Section 4.3.1, we obtain correspondingly Sc∗(j) and Sc(j) with c
∗ = −0.6 and c = −0.4.
We obtain the optimal values of (ϕ1, ϕ2, γ0) using (5.6) with S
∗
P (k) and Sˆ
∗(k) replaced by
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Figure 5.1: True, observed, and approximated true survival functions with lower detection
limits with c∗ = −0.6 and c = −0.4 for ρ1 = 0.5 and ρ2 = 0.5 (a) and ρ1 = 1 and ρ2 = 0
(b).
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Sc∗(j) and S
∗
c (j), correspondingly. The optimal values of (ϕ1, ϕ2, γ0) are (1, 0.0004, 0.819)
and (1, 0.0005, 0.819) for ρ1 = 0.5 and ρ2 = 0.5 and for ρ1 = 1 and ρ2 = 0, respectively.
The approximated survival functions are shown in Figure 5.1. We observe from Figure
5.1 that (i) the observed survival rates are greater than true survival rates; and (ii) the
approximated survival function almost overlap the true survival function.
5.5 Upper Limit Detection Problem under Gamma Process
Now, we discuss the upper detection limit problem focused on Gamma process and
derive lemmas, theorem, and corollary for that. Under the gamma process discussed in
4.3.1, if we consider the upper limit of detection level as c, then survival function at time
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tj is
Sc(j) = P (X1 ≤ 1 + c,X1 +X2 ≤ 2 + c, . . . ,X1 + · · ·+Xj ≤ n+ c).
Using the same transformation for the low limit detection problem from (X1, . . . , Xj) to
(W1, . . . ,Wj), where Wj = X1 + · · ·+Xj for j = 1, 2, . . . , we can rewrite Sc(j) as
Sc(j) =
∫ c+1
0
∫ c+2
0
· · ·
∫ c+j
0
exp(−wj)1(w1 ≤ · · · ≤ wj−1 ≤ wj)dwj · · · dw2dw1
=
∫ c+1
0
∫ c+j−(j−2)
w1
· · ·
∫ c+j
w(j−1)
exp(−wj)dwj · · · dw2dw1.
Define a new sequence of random variables as Y1 = Wj , . . . , Yj = W1. Then, S
c(j) is given
by
Sc(j) =
∫ c+1
0
∫ c+j−(j−2)
yj
· · ·
∫ c+j
y2
exp(−y1)dy1 · · · dy(j−1)dyj .
To obtain a general expression of Sc(j), define a new sequential function Un(y, b) as
Un(y, b) =
∫ b−(n−2)
y
U(n−1)(z, b)dz (5.7)
for n = 2, 2, . . . , where U1(y, b) = exp (−y). We derive an iterative expression for Un(y, b)
in Lemma 5.5.1.
Lemma 5.5.1. The sequence Un(y, c+ n) can be expressed as
Un(y, b) = Un−1(y, b− 1) + exp (−b)
[(b− y)(n−3)
(n− 3)! I(n ≥ 3)−
(b− y)(n−2)
(n− 2)!
]
, (5.8)
for n = 2, 3, . . . , where U1(y, b) = exp (−y) and I(a) is the indicator function that takes a
value of 1 if a is true and 0 otherwise.
The proof of Lemma 5.5.1 is given in Appendix. From (5.7), we have
Un(yn, b) =
∫ b−(n−2)
yn
Un−1(yn−1, b)dyn−1
=
∫ b−(n−2)
yn
· · ·
∫ b
y2
exp(−y1)dy1 · · · dyn−1,
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for n = 2, . . . where U1(y1, b) = exp (−y1) and Sc(j) =
∫ c+1
0 Uj(y, c + j)dy for j = 1, . . . .
Using Lemma 5.5.1, we discuss a sequential relationship of the survival function, Sc(j) in
the next Lemma.
Lemma 5.5.2. Suppose that the Xj are i.i.d. from Gamma(1, 1) for j = 1, . . . . Then,
the survival function at time tj with an upper detection limit c has the relationship as
follows
Sc(j) = P (X1 ≤ 1 + c,X1 +X2 ≤ 2 + c, . . . ,X1 + · · ·+Xj ≤ n+ c)
= Sc(j − 1)− exp {−(c+ j)}
(j − 1)!
[
(c+ j)(j−2){(c+ j)− (j − 1)I(j ≥ 3)}]
+
exp {−(c+ j)}
(j − 1)!
[
(j − 1)(j−1)I(j = 2)], (5.9)
for j = 1, 2, . . . where Sc(0) = 1.
The proof of Lemma 5.5.2 is given in Appendix. Using Lemma 5.5.2, an explicit expression
of the survival function is given in the following theorem.
Theorem 5.5.3. Suppose that the Xj are i.i.d. from Gamma(1, 1) for j = 1, . . . . Then,
the survival function at time tj with an upper detection limit c is given by
Sc(j) = 1−
j∑
k=1
[exp {−(c+ k)}
(k − 1)!
{
(c+ 1)(c+ k)(k−2)
}I(k≥2)]
.
The proof of Theorem 5.4.2 directly follows from Lemma (4.2.1), (i) of Proposition 5.4.1
and (ii) of Proposition 4.2.3.
Similar to the low limit detection problem, we can extend Theorem 5.5.3 with Xj ∼
Gamma(1, λ). Since
Xj
λ ∼ Gamma(1, 1), we have
S(c,λ)(j) = P (X1 ≤ λ+ c,X1 +X2 ≤ 2λ+ c, . . . ,X1 + · · ·+Xj ≤ nλ+ c)
= P (
X1
λ
≤ 1 + c
λ
,
X1 +X2
λ
≤ 2 + c
λ
, . . . ,
X1 + · · ·+Xj
λ
≤ n+ c
λ
). (5.10)
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Figure 5.2: True, observed, and approximated true survival functions with upper detection
limits with c∗ = −0.4 and c = −0.8 for ρ1 = 0.5 and ρ2 = 0.5 (a) and ρ1 = 1 and ρ2 = 0
(b).
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Using (5.10), S(c,λ)(j) with Xj ∼ Gamma(1, λ) can be obtained in the next corollary.
Corollary 5.5.4. Suppose that the Xj are i.i.d. from Gamma(1, λ) for j = 1, . . . . Then,
the survival function at time tj with an upper detection limit c is given by
S(c,λ)(j) = P (X1 ≤ λ+ c,X1 +X2 ≤ 2λ+ c, . . . ,X1 + · · ·+Xj ≤ nλ+ c) = S cλ (j).
If the upper limit of gold standard test is upper than that of error prone test under
the upper detection limit problem, then P (T ∗ ≥ T ) in Assumption 4.1 is reasonable. This
indicates P (T ∗ ≥ T ) = 1 if c∗ ≥ c.
To exam our proposed model in (4.3) for the upper limit detection problem, in which
P (T ∗ ≥ T ) = 1, we consider two different detection limits for the true and observed events
as c∗ = −0.4, and c = −0.8. After that, we obtain the approximated survival function
using the optimal values of (ω1, ω2, τ0) , which minimize (4.11) for ρ1 = 0.5 and ρ2 = 0.5
86
Figure 5.3: True, observed, and approximated true survival functions with upper detection
limits with c∗ = −0.6 and c = −0.4 for ρ1 = 0.5 and ρ2 = 0.5 (a) and ρ1 = 1 and ρ2 = 0
(b).
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and for ρ1 = 1 and ρ2 = 0 for w(k). The pairs of estimates are (0.136, 0.000, 0.701) and
(0.150, 0.000, 0.694) for ρ1 = 0.5 and ρ2 = 0.5 and for ρ1 = 1 and ρ2 = 0, respectively.
Figure 5.2 shows true (blue solid line), observed (red solid line), and approximated (green
dashed line) true survival function. Similar to Figure 4.1, the approximated true survival
function is much closer to the true survival function than the observed survival function.
As we extend low limit detection problem under Assumption 4.1 to Assumption 5.1,
we assume T ∗ ≤ T under upper detection limit problem and test the model in 4.4 under
Gamma process. The approximated true survival function is obtained from the optimal
values of (ϕ1, ϕ2, γ0 ), which minimize (5.6) for ρ1 = 0.5 and ρ2 = 0.5 and for ρ1 = 1 and
ρ2 = 0 for w(k). The pairs of estimates are (0.813, 0.049, 0.730) and (0.809, 0.051, 0.730)
for ρ1 = 0.5 and ρ2 = 0.5 and for ρ1 = 1 and ρ2 = 0 for w(k), respectively. Figure 5.3
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shows true (blue solid line), observed (red solid line), and approximated (green dashed
line) true survival function. Similar to the results in Section 5.4, we observe from Figure
5.3 that the approximated true survival function almost overlap the true survival function.
The observation from the Figure 5.2 and 5.3 confirm that the proposed models in 4.3
and 4.4 work well for the upper detection limit problem under Gamma process.
Appendix A
Proofs of Theorems
A.1 Proof of Theorem 2.3.1
By setting c = x′β and from (2.13), −∑∞k=1 log{1−F (αk+x′β)} <∞ and −∑∞k=1 log{1−
F (αk + x
′β)} =∞ are equivalent S(∞|x,β) > 0 and S(∞|x,β) = 0, respectively. Thus,
to prove Theorem 2.3.1, it suffices to show that −∑∞k=1 log{1−F (αk+x′β)} is finite. We
first prove the first part of Theorem 2.3.1. Since -log(1− y) is convex on y ∈ [0, F (0)], we
have − log(1 − y) ≤ − log{1−F (0)}F (0) y for y ∈ [0, F (0)]. Letting y = F (αi + x′β) and under
Assumption 2.1, we obtain
−
∞∑
i=1
log{1− F (αi + x′β)}
≤ −
k0−1∑
i=1
log{1− F (αi + x′β)} − log(1− F (0))
F (0)
∞∑
i=k0
F (αi + x
′β)
≤ −
k0−1∑
i=1
log{1− F (αi + x′β)} − log(1− F (0))
F (0)
d
∞∑
i=k0
exp(αi + x
′β)
<∞,
which implies S(∞|x,β) > 0. Similarly, we can show the second part of Theorem 2.3.1.
The detail is omitted here. Thus, we complete the proof.
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A.2 Proof of Theorem 2.3.2
For (i), under the C-log-log link, we have
−
∞∑
k=1
log{1− F (αk + x′β)} =
∞∑
k=1
exp(αk + x
′β).
Therefore, S(∞|x,β) > 0 if and only if ∑∞k=1 exp(αk) < ∞. Under the logit link, the
sufficiency immediately follows from Remark 2.1 and (2.22). To prove the necessity, we
need to show that
∑∞
k=1 exp(αk) =∞ implies S(∞) = 0. When
∑∞
k=1 exp(αk) =∞, then
one of the following two cases must hold:
(a) there exists k0 such that
exp(αk + x
′β) ≤ 2 for all k ≥ k0;
(b) there exists a subsequence, {kj , j = 1, 2, . . . }, such that
exp(αkj + x
′β) > 2 for all j ≥ 1.
Since log(1 + y) is concave on (0, 2], it is easy to see that log(1 + y) ≥ log 32 y for 0 < y < 2.
When (a) is true, we have
S(∞|x,β) = lim
k→∞
S(k|x,β)
= S(k0|x,β) exp[−
∞∑
i=k0+1
log{1 + exp(αi + x′β)}]
≤ S(k0|x,β) exp
[
−
∞∑
i=k0+1
log 3
2
exp(αi + x
′β)
]
= 0,
since
∑∞
k=1 exp(αk) =∞. When (b) is true, it is obvious that
1
1 + exp(αkj + x
′β)
<
1
3
,
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for all j = 1, 2, · · · . This indicates that
S(∞|x,β) =
∞∏
k=1
1
1 + exp(αk + x′β)
≤
∞∏
j=1
1
1 + exp(αkj + x
′β)
≤ lim
j→∞
1
3j
= 0.
For (ii), the sufficiency directly follows from Remark 2.2 and Theorem 2.3.1. To prove
the necessity, without loss of generality, assume −αk − x′β > 1 for all k ≥ k0. Using the
fact, d1(−αk−c)ν ≤ F (αk + c) ≤
d2
(−αk−c)ν with r = ν, we have
−
∞∑
k=k0
log
{
1− d1
(−αk − x′β)r
}
≤ −
∞∑
k=k0
log{1− F (αk + x′β)}, (A.1)
where d1 is defined in Remark 2.2.
Since g(y) = y + log(1− y) is a decreasing function of y when y ∈ (0, 1) and g(0) = 0,
log(1− y) + y ≤ 0 for y ∈ (0, 1). Letting y = d1
(−αk−x′β)r , we obtain
∞∑
k=k0
d1
(−αk − x′β)r ≤ −
∞∑
k=k0
log
{
1− d1
(−αk − x′β)r
}
. (A.2)
Thus, using (A.1) and (A.2), (2.23) holds if the survival function is improper, i.e., −∑∞k=k0 log{1−
F (αk + x
′β)} <∞.
A.3 Proof of Theorem 2.3.4
For (i), since αk is a linear model (2.24), we have
∞∑
k=1
exp(αk) = exp(ψ0)
∞∑
k=1
exp(ψ1)
tk .
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Based on Theorem 1, it is sufficient to show
∑∞
k=1 exp(ψ1)
tk <∞. Since tk ∈ (j− 1, j] for
any k ∈ Nj and exp(ψ1) < 1 if ψ1 < 0, we have
∞∑
k=1
exp(ψ1)
tk =
∞∑
j=1
∑
k∈Nj
exp(ψ1)
tk
≤
∞∑
j=1
∑
k∈Nj
exp(ψ1)
j−1
≤ Nmax
∞∑
j=1
exp(ψ1)
j−1.
Since
∑∞
j=j0
{exp(ψ1)}j−1 < ∞ and Nmax < ∞, we have
∑∞
k=1 exp(ψ1)
tk < ∞. By
Theorem 1, the survival function is improper. For the proof of (ii), we want to show
that
∑∞
k=k0
1
(−αk−c)r < ∞ for a given k0 based on Theorem 1. Let k0 ∈ Nj∗ and c =
x′β. Without loss of generality, let −αk − c ≥ 2 for all k ∈ Nj∗−1, which implies that
−ψ0 − ψ1(j − 1) − c > 2 for all j ≥ j∗, if ψ1 < 0. With r > 1 and ψ1 < 0, we have as
follows
∞∑
k=k0
1
(−αk − c)r ≤
∞∑
j=j∗
∑
k∈Nj
1
{−ψ0 − ψ1tk − c}r
≤
∞∑
j=j∗
∑
k∈Nj
1
{−ψ0 − ψ1(j − 1)− c}r
≤ Nmax
∞∑
j=j∗
1
{−ψ0 − ψ1(j − 1)− c}r <∞.
By Theorem 2.3.1, the survival function is improper.
A.4 Proof of Theorem 2.3.6
F ( lim
k→∞
αk + x
′β) ≤ lim
k→∞
S(k|x,β) ≤ F ( lim
k→∞
αk + x
′β). (A.3)
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If limk→∞ αk = c0 for c ∈ (−∞,∞), then limk→∞ αk +x′β = c0 and F (c0) > 0. Similarly,
if survival function is improper, i.e., S(∞|x,β) = cs > 0, then limk→∞ αk+x′β > F−1(cs).
Since αk is strictly decreasing and bounded below, αk is convergent to a constant c0.
A.5 Proof of Lemma 4.2.1
S∗(j) = Pr(T ∗ > tj |T ≤ tj)P (T ≤ tj) + Pr(T ∗ > tj |T > tj)P (T > tj)
= {1− Pr(T ∗ ≤ tj |T ≤ tj)}{1− P (T > tj)}+ Pr(T ∗ > tj |T > tj)P (T > tj).
Using the definition of PPV and NPV in (4.2), we obtain Lemma 4.2.1.
A.6 Proof of Proposition 4.2.2
For (i), it is trivial by considering j=1, k=1 in 4.3. For (ii), Using iv) in Remark 1, it
can be easily obtained. For (iii), it is obvious for the first part of (iii) and for the last part,
since P (T ∗ ≤ tj |T = tk) = 1 −
{
1 − τ0
}(j−1)ω1+1 for all tk ≤ tj , which is constant for tk
and
∑j
k=1 P (T = tk) = P (T ≤ tj), the proof is done. For (iv), it is trivial by considering
P (T ∗ ≤ tj |T = tk) = τ0 for the proof of (iii).
A.7 Proof of Theorem 4.2.7
By Theorem 5 of Breslow and Crowley (1974), let tK < ∞ satisfy 1 − S(j|x) < 1. Then
the random variable
√
n(Sˆ(j) − S(j)), for 0 < j < K, converges weakly to a mean zero
normal random variable Zj . Moreover,
Cov(Zj , Zk) = S(j)S(k)
j∑
t=0
(S(t))−2(1−H(tj))−1P (Et = 1), j ≤ k,
where 1−H(tj) is the right censoring distribution function. Since Sˆ∗(j) is a linear combi-
nation of the KM estimator, it therefore follows an asymptotically normal distribution.
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A.8 Proof of Lemma 4.3.1
For n=2, B2(c, x) =
∫ x
c+1B1(c, u)du = x − (c + 1) = (x−c)1! − 1, which is true. Suppose it
is true for n = k, then Bc, k+1(x) is obtained as follows
Bk+1(c, x) =
∫ x
c+k
Bk(c, u)du
=
∫ x
c+k
(u− c)k−1
(k − 1)! −
(u− c)k−2
(k − 2)! du
=
(x− c)k
k!
− k
k
k!
− (x− c)
k−1
(k − 1)! +
kk−1
(k − 1)! .
Since −kkk! + k
k−1
(k−1)! =
kk−kk
k! = 0, we obtain that
Bk+1(c, x) =
(x− c)k
k!
− (x− c)
k−1
(k − 1)! ,
which is true for n = k + 1. By induction, we complete the proof.
A.9 Proof of Proposition 4.2.4
(i)We can rewrite γj(x) = P (T
∗ > tj |T > tj) as γj = 1 − P (T ∗ ≤ tj |T > tj). Under the
Assumption 4.1, P (T ∗ ≤ tj |T > tj) = 0. (ii) τj = P (T ∗ ≤ tj |T ≤ tj) = P (T
∗≤tj ,T≤tj)
P (T≤tj) .
Under Assumption 4.1, we have P (T ∗ ≤ tj , T ≤ tj) = P (T ∗ ≤ tj),which completes the
proof.
A.10 Proof of Theorem 4.3.2
We have Sc(1) = exp {−(c+ j)}, which implies it is true for j = 1. To prove for j ≥ 2,
let Gn(a) =
∫∞
a u
n exp (−u)du. Then, it is easily obtained that Gn(a) = an exp (−a) +
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nGn−1(a) =
∑n
m=0
n!
(n−m)!a
(n−m) exp (−a). Using that fact and the Lemma 4.3.1, we have
Sc(j) =
∫ ∞
c+j
exp (−wj)Bj(c, wj)dwj
=
∫ ∞
c+j
exp (−wj)
[(wj − c)j−1
(j − 1)! −
(wj − c)j−2
(j − 2)!
]
dwj
=
j−1∑
m=0
jm
m!
exp {−(c+ j)} −
j−2∑
m=0
jm
m!
exp {−(c+ j)} = j
(j−1)
(j − 1)! exp {−(c+ j)},
which complete the proof.
A.11 Proof of Lemma 5.5.1
For n = 2, U2(y, b) =
∫ c+2
y U1(z, b)dz =
∫ c+2
y exp (−z)dz = exp (−y) − exp {−(c+ 2)},
which is true. Suppose it is true for n = k and k ≥ 3, which means
Uk(y, b) = Uk−1(y, b− 1) + exp (−b)
[(b− y)(k−3)
(k − 3)! −
(b− y)(k−2)
(k − 2)!
]
.
Then, for n = k + 1 we have
Uk+1(y, b) =
∫ b−(k−1)
y
Uk(z, b)dz
=
∫ b−1−(k−2)
y
Uk−1(z, b− 1)dz +
∫ b−(k−1)
y
exp {−b}
[(b− z)(k−3)
(k − 3)! −
(b− z)(k−2)
(k − 2)!
]
dz
= Uk(y, b− 1) + exp (−b)
[
− (b− z)
(k−2)
(k − 2)!
∣∣∣b−(k−1)
y
+
(b− z)(k−1)
(k − 1)!
∣∣∣b−(k−1)
y
]
.
Since we have
exp (−b)
[
− (b− z)
(k−2)
(k − 2)!
∣∣∣b−(k−1)
y
+
(b− z)(k−1)
(k − 1)!
∣∣∣b−(k−1)
y
]
= exp (−b)
[
− (k − 1)
(k−2)
(k − 2)! +
(b− y)(k−2)
(k − 2)! +
(k − 1)(k−1)
(k − 1)! −
(b− y)(k−1)
(k − 1)!
]
= exp (−b)
[(b− y)(k−2)
(k − 2)! −
(b− y)(k−1)
(k − 1)!
]
we obtain Uk+1(y, b) = Uk(y, b− 1) + exp (−b)
[
(b−y)(k−2)
(k−2)! − (b−y)
(k−1)
(k−1)!
]
, which implies it is
true for n = k + 1. By induction, the proof is completed.
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A.12 Proof of Lemma 5.5.2
Since Sc(j) =
∫ c+1
0 Uj(y, c+ j)dy, using Lemma 5.5.1 we have
Sc(j) =
∫ c+1
0
Uj(y, c+ j)dy
=
∫ c+1
0
Uj−1(y, c+ j − 1)dy
+ exp {−(c+ j)}
∫ c+1
0
[(c+ j − y)(j−3)
(j − 3)! I(j ≥ 3)−
(c+ j − y)(j−2)
(j − 2)!
]
dy
Since
∫ c+1
0 Uj−1(y, c+ j − 1)dy = Sc(j − 1), and∫ c+1
0
(c+ j − y)(j−2)
(j − 2)! = −
(c+ j − y)(j−1)
(j − 1)!
∣∣c+1
0
= −(j − 1)
(j−1)
(j − 1)! +
(c+ j)(j−1)
(j − 1)! ,
we have
Sc(j) = Sc(j − 1)− exp {−(c+ j)}
[(j − 1)(j−2)
(j − 2)! I(j ≥ 3)−
(c+ j)(j−2)
(j − 2)! I(j ≥ 3)
]
+ exp {−(c+ j)}
[(j − 1)(j−1)
(j − 1)! −
(c+ j)(j−1)
(j − 1)!
]
= Sc(j − 1)− exp {−(c+ j)}
[{(j − 1)(j−1) − (j − 1)(c+ j)(j−2)}I(j ≥ 3)
(j − 1)!
]
+ exp {−(c+ j)}
[(j − 1)(j−1) − (c+ j)(j−1)
(j − 1)!
]
=Sc(j − 1)− exp {−(c+ j)}
(j − 1)!
[
(c+ j)(j−2){(c+ j)− (j − 1)I(j ≥ 3)}]
+
exp {−(c+ j)}
(j − 1)!
[
(j − 1)(j−1)I(j = 2)],
which complete the proof.
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